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Abstract 
Almost half of commercial pharmaceuticals are chiral and therefore effective analytical 
techniques to detect and quantify enantiomers are important in the pharmaceutical 
sector to ensure drug safety and efficacy. 
In this work copper(II) complexes of aminoalkane derivatives of β-cyclodextrin (CDEn, 
CDPn and CDBn) were investigated to determine if they provide a versatile solution for  
the direct separation of the enantiomers of DOPA, benserazide and carbidopa using 
capillary electrophoresis. Tyrosine was used as a model compound.  
Electronic spectroscopy was used in order to determine if copper(II) coordinates to the 
amino-CDs and to determine if further coordination to the guest species occurs. 
Decreases in λmax for the d-d transitions on coordination of the metal ion suggest the 
formation of a CuCDAm binary complex with CDEn and CDPn acting as bidentate 
ligands and CDBn acting as a monodentate ligand. A further blue shift on the 
introduction of a guest species suggests further coordination of copper(II) and formation 
of ternary complexes of tyrosine and DOPA with all three metallo-complexes of the 
aminoalkane derivatives. A ternary complex also formed between CuCDEn and L-
carbidopa. No coordination was evident with benserazide. These results suggest that the 
use of these metallo-cyclodextrin derivatives for enantioselection may be guest specific 
if ternary complex formation is required for separation. 
Cicular dichroism (c.d.) can show the differential inclusion of enantiomers in 
cyclodextrin cavities and therefore was used here to determine if the metallo-
cyclodextrins can differentiate between enantiomers. Increases in intensity of the bands 
in the spectra indicate deeper inclusion of a guest in the CD cavity. From the results 
obtained in this study it can be shown that the binary complex CuCDEn is the most 
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enantioselective material of those studied towards both tyrosine and DOPA. CuCDPn 
and CuCDBn showed no enantioselection. 
The stoichiometry of all complexes was determined using electronic spectroscopy and 
Job’s method of continuous variation. A 1:1 binary complex formed between Cu(II) and 
CDEn. It was also shown that CuCDEn formed a 1:1 ternary complex with tyrosine and 
a 2:1 complex with DOPA. Results also suggested that both 1:1 and 2:1 complexes of 
CuCDEn and L-carbidopa were formed.  
Using CE in normal polarity mode and a background electrolyte (BGE) at pH 6.8, 
separation of the enantiomers of DOPA was not achieved using CuCDEn as a chiral 
selector. The stability of the binary complex is limited by pH and therefore CDEn alone 
was used as the chiral selector. Separation of L-DOPA from L-carbidopa was achieved 
using CDEn in a BGE at pH 2.5 and a resolution of 2.36 was obtained. However it was 
still not possible to separate the isomers of DOPA. An alternative charged CD 
derivative, sulfated-β-cyclodextrin was investigated and was found to successfully 
separate the enantiomers of D,L-DOPA in a BGE of pH 2.5 and a resolution of  3.62 was 
obtained.  
These results suggest that amino-cyclodextrin derivatives are guest specific for chiral 
separations in capillary electrophoresis and do not represent a universal method for 
separations required for regulatory compliance. Since separations were obtained using 
the anionic sulfated derivatives it is suggested that host molecules with a permanent 
charge are more useful and therefore inclusion is not the only factor needed for 
separation to be successful. 
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1.1 Introduction 
Chiral molecules lack an internal plane of symmetry and have non-superimposable 
mirror images. They are extremely important in the pharmaceutical industry with 56 % 
of drugs currently in use being chiral compounds and a further 88% of these chiral 
drugs being used as racemates.1  An example of such a racemate is D,L-sotalol (D-
sotalol is an anti-arrhythmic while L-sotalol is a beta-blocker).2   
1.1.1 Isomerism 
The renowned French chemist Louis Pasteur is credited with the discovery of the 
existence of molecular chirality and isomerism. He found that the sodium ammonium 
salt of racemic tartaric acid crystallised as a mixture of two different crystals, which he 
separated using a microscope and tweezers.3 He postulated that the isomers have 
different three-dimensional arrangements of atoms, and are non-superimposable mirror 
images of one another, both on a macro scale and on a micro scale.   
Isomers are compounds with the same molecular formula, but vary in the orientation or 
connectivity of atoms and can be divided into two classes, constitutional isomers and 
stereoisomers. Constitutional isomers have the same molecular formula but differ in the 
way their atoms are connected.  Examples of constitutional isomers 1-propanol, 2-
propanol and ethyl methyl ether can be seen in Figure 1.1.  
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HO
1-propanol
HO
2-propanol
O
ethyl methyl ether
C3H8O
 
Figure 1.1 Constitutional isomers of C3H8O 
Unlike the atoms in constitutional isomers, the atoms in stereoisomers have the same 
connectivity but are different in their three-dimensional orientation in space. 
Stereoisomers can be further subdivided into two distinct groups, enantiomers and 
diastereoisomers.4  
Enantiomers are defined as stereoisomers with the same molecular formula that are non-
superimposable mirror images i.e. chiral molecules. They possess identical physical 
properties such as melting point, boiling point and solubility.  Enantiomers behave in 
the same manner when reacted with an achiral molecule, but react differently to one 
another when reacted with another chiral compound. Diastereoisomers are 
stereoisomers that have the same molecular formula but are not mirror images of each 
other and unlike enantiomers they do have different physical properties. Figure 1.2 
gives an overview of isomerism.  
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Figure 1.2 Overview of isomerism5 
The most important difference between enantiomers is their interaction with plane 
polarised light.  Plane polarised light oscillates in one plane only and when passed 
through a solution of one pure enantiomer of a compound it is rotated, the angle of 
rotation being an inherent property of the material. Therefore enantiomers are also 
called optical isomers. One of the enantiomers will rotate the plane clockwise to the 
right and is labelled the (+) enantiomer, while the other enantiomer will rotate the plane 
by an equivalent angle to the left and is labelled (-). A racemic solution contains the 
same concentration of the two enantiomers and will give no overall rotation of the plane 
polarised light.  
1.1.2 Designating Isomers 
Chiral molecules were named initially using (+) and (-) signs or d (dextro) and l (levo) 
indicating the direction in which the enantiomers rotate the plane of polarised light. d or 
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(+) denotes rotation to the right (clockwise) and l or (-) rotation to the left (anti-
clockwise). However there is the possibility of confusion with the designation D or L 
used for amino acids and carbohydrates.  
Emil Fischer is credited with the designation of isomers of both carbohydrates and 
amino acids. By drawing a molecule of glyceraldehyde in a two-dimensional form 
(Fischer Projection) he defined one isomer as being D on the basis that the hydroxyl 
group attached to C2 is on the right hand side of the molecule. The other enantiomer is 
defined as L because the hydroxyl group is situated on the left hand side of the 
molecule. 
CH
OHH
CH2OH
O CH
HHO
CH2OH
O
D-glyceraldehyde L-glyceraldehyde
1 1
2 2
3 3
 
Figure 1.3 Fischer projections of the isomers of glyceraldehyde with carbon atoms numbered 
This notation was also extended to the assignment of amino acids.  L enantiomers are 
those in which the amino group is on the left hand side of the Fischer projection (when 
the carboxyl group appears at the top).  Conversely the D enantiomers are those in 
which the amino group is on the right hand side. 
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1 1
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3 3
 
Figure 1.4 Fischer projections of the isomers of alanine 
The drawback to all these systems of nomenclature is that they either only relate to 
optical activity or are somewhat ambiguous for definitive structural configuration. To 
overcome these difficulties the Cahn–Ingold–Prelog system was introduced. 
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Cahn-Ingold-Prelog notation (CIP notation) provides an unambiguous description of a 
stereoisomer of a compound. The assignment of R or S according to CIP notation 
follows a sequence of rules shown in Figure 1.5. In step 1 the groups are prioritised on 
the basis of the decrease in the atomic number of the atoms directly bonded to the centre 
of chirality. In cases where two or more of these atoms are identical, the next bonded 
atoms have to be considered and then eventually the third bonded atoms and so on. The 
branch containing the atom with the highest atomic number has the highest priority. In 
step 2 the group of lowest priority is rotated to the back. Finally the R configuration is 
determined as the structure, where the increasing order of priority (1 to 4) is clockwise. 
The S configuration shows the increasing order of priority in a counter-clockwise 
direction. It is important to note however, that the designation of R and S is independent 
of the direction the isomers rotate plane polarised light.  
 
 
Prioritise the 
substituent groups
CH3
Cl
H
HO
3
1
4
2
Rotate lowest priority
group to back
CH3
OH
Cl
H
3
1
4
2
Counter-clockwise order
of priority indicates the 
S configuration
CH3
Cl
H
HO Step 1 Step 2
CH3
OH
Cl
H
3
1
4
2
 
Figure 1.5 Selection rules for Cahn-Ingold-Prelog notation 
Chapter 1 Introduction 
8 
 
 
1.1.3 Chiral Pharmaceuticals 
The majority of racemic pharmaceuticals have one major bioactive enantiomer 
(eutomer) and a less bioactive enantiomer (distomer). The distomer can be toxic or even 
exert a totally undesired pharmacological affect.6  It is also possible for racemic drugs 
to have equally bioactive enantiomers. Cyclophosphamide (anti-neoplastic), flecainide 
(anti-arrhythmic) and fluoxetine (anti-depressant) are among this latter group.7  
O NH
P
O N
Cyclophosphamide
O
NH
O
CF3
O
F3C
HN
Flecainide
O
CF3
NH
Fluoxetine  
Figure 1.6 Structures of cyclophosphamide, flecainide and fluoxetine 
A third group of racemic drugs also exists, where chiral inversion can take place. This 
can happen in two ways, unidirectional and bidirectional conversion. Ibuprofen falls 
into the category of unidirectional conversion, where only the S enantiomer is active 
(analgesic / anti-inflammatory) but a significant amount of the R enantiomer is 
converted to S (and not vice versa) in vivo.  
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  H CH3
OH
O
H3C H
OH
O
S-Ibuprofen R-Ibuprofen  
Figure 1.7 Structures of S and R-ibuprofen 
Therefore, even when ibuprofen is administered in racemic form, the drug exhibits 75% 
of the activity of the pure S form at the same dose level.8  
Thalidomide is a famous example of bidirectional conversion (racemisation). 
Thalidomide was a racemic sedative removed from the market in the 1960s due to 
severe teratogenic side-effects. It was discovered that the S enantiomer was responsible 
for these ill effects. However administration of the R enantiomer alone would have 
made no difference as the thalidomide enantiomers can interconvert. It was this case 
that started the drive to treat the undesirable enantiomer as an unwanted component or 
indeed an impurity which must be eliminated.  
 
N
O
O
NH
O
O
H
N
O
O
NH
O
O
H
S-Thalidomide R-Thalidomide
 
Figure 1.8 Structures of S and R-thalidomide 
The drug studied in this work is dihydroxyphenylalanine (DOPA) which is the most 
effective drug at present for Parkinson’s disease which results from reduced levels of 
dopamine in the brain. L-DOPA is the active isomer and is converted to dopamine via 
decarboxylation catalysed by L-amino acid decarboxylase (L-DOPA decarboxylase). D-
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DOPA is inactive. Dopamine itself cannot be used to treat the disease since it cannot 
cross the blood-brain barrier. L-DOPA however can undergo extracerebral 
decarboxylation to dopamine and is therefore administered in conjunction with the 
inhibitor carbidopa. Benserazide can also inhibit decarboxylation. Both inhibitors do not 
cross the blood-brain barrier and therefore do not inhibit conversion of L-DOPA to 
dopamine in the brain. The amino acid tyrosine is used as a simpler model compound in 
this work and is also a precursor in the synthesis of L-DOPA. The structures of the 
compounds studied are given in Figure 1.9.  
  NH2O
HO OH
Tyrosine
OHOHO
HO NH2
DOPA
O
HO
CH3
NH2
HN
OH
OH
Carbidopa
OH
HO
HO
N
H
H
N OH
O
NH2
Benserazide  
Figure 1.9 Structures of tyrosine, DOPA, benserazide and carbidopa 
In 1992 the Food and Drug Administration (FDA) issued a policy statement 
encouraging pharmaceutical companies to use recent advances in synthetic and 
separation techniques to develop single enantiomeric drugs.   
“The stereoisomeric composition of a drug with a chiral centre should be known and 
the quantitative isomeric composition of the material used in pharmacologic, 
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toxicologic, and clinical studies should be known.  Specifications for the final product 
should assure identity, strength, quality, and purity from a stereochemical viewpoint”.2  
“When the drug product is a racemate and the pharmacokinetic profiles (what the body 
does to the drug) of the isomers are different, manufacturers should monitor the 
enantiomers individually to determine such properties as dose linearity and the effects 
of altered metabolic or excretory function and drug-drug interactions”.2   
Therefore there is a need for methods for the separation and analysis of chiral materials. 
BCC Market Research has predicted that the market for chiral synthesis, resolution and 
analysis of products will grow at 2.8 per cent per year and reach $5.1 billion by 2014. 
Much of this growth is due to the pharmaceutical industry’s development of chirally 
pure drugs, encouraged by FDA policies.9 
1.1.4 Current Separation Methods for Chiral Pharmaceuticals 
Enantiomers share many of the same characteristic properties e.g. boiling point, melting 
point, solubility, molecular weight and size, therefore making their separation difficult. 
Clearly the ideal way to obtain a pure single enantiomeric drug would be to employ 
enantioselective synthesis. However this is not always a practical or cost effective 
option. Therefore, the separation of racemic mixtures of intermediates or final products 
is a common practice.  To carry out enantiomeric separation a number of 
chromatographic techniques exist including, high performance liquid chromatography 
(HPLC), gas chromatography (GC), supercritical fluid chromatography (SFC) and thin 
layer chromatography (TLC).10 More recently several electrophoretic techniques have 
become popular such as capillary electrophoresis (CE).11,12 A review by Timothy J. 
Ward and Karen D. Ward of chiral separations publications from 2008 to 2010 showed 
that HPLC and CE are the most widely used techniques in the field. Of the two 
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techniques HPLC is by far the most used with a conservative estimate of 1000 
publications on chiral separations appearing in the two year period.13  
Chiral separations by CE and HPLC can be broken down into two classifications, 
indirect and direct separation. Indirect separation involves reaction of the enantiomers 
with an enantiomerically pure reagent followed by the separation of the diastereomeric 
derivatives by HPLC or CE. This approach can be particularly advantageous if strongly 
UV absorbing or fluorescent derivatives are produced, which can lead to an increase in 
the limit of detection by electronic absorption or fluorescence. However using this 
method requires reagents of high stereochemical purity and includes extra synthetic 
steps leading to an increase in cost and time of analysis. Examples of some 
derivatisation reagents include (+)-1(9-fluorenyl)ethyl chloroformate (FLEC), 2,3,4,6-
tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate (GITC) and Marfey’s reagent which 
are used in the separation and detection of amino acids.14 
N+
N+
H
N
O O-
O
-O
O
NH2
Marfey's Reagent FLEC
H3C O Cl
O
O
O
O
N
C
S
O
O
O
O
O
O
GITC  
Figure 1.10 Structures of some chiral derivitisation reagents 
Direct separations require the presence of a chiral selector which is able to form 
transient diastereomeric complexes with the analyte enantiomers. In CE the selector can 
be added to the background electrolyte (BGE), while in HPLC the selector can be 
dissolved in the mobile phase. It is also possible to have the chiral selector present in the 
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packing material of the column i.e. chiral stationary phase (CSP). Examples of some 
chiral selectors are cyclodextrins and their derivatives, chiral crown ethers and 
macrocyclic antibodies. Molecularly imprinted polymers are also used to a lesser 
extent.13 
HPLC is considered the industry standard for analytical separations. However there are 
many economic disadvantages associated with the method such as the initial cost of the 
instruments and the cost of large volumes of solvents. Also indirect chiral separations 
generally require derivatisation of the analyte under investigation which can be time 
consuming and can lead to longer analysis times due to the extra sample preparation 
step. Direct methods for chiral separations, which are becoming more popular with 
advances in column manufacturing, use specialised column packing. Here cyclodextrins 
have found a role, but the disadvantage is that these columns are expensive and have 
low versatility. Take for example a Phenomenex Chirex column, containing D-
penicillamine with a metal ion linker which can be used for ligand exchange chiral 
separations. This column costs in the region of €1,400 to €1,560 (excluding VAT) 
depending on column dimensions, which compares to ~ €300 for a commonly used C18 
column. The versatility of many these chiral columns can be quite poor whereby they 
are only effective for one class of analytes. 
Capillary electrophoresis (CE) on the other hand consists of simpler less expensive 
equipment, uses millilitre quantities of solvent (usually inexpensive aqueous buffers) 
and milligram quantities of chiral selectors. Also capillaries cost in the region of €60 
each (excluding VAT) and have theoretical plate numbers measured in the hundreds of 
thousands compared to thousands for HPLC. Disadvantages of CE include its inability 
to perform preparative scale separations, issues with reproducibility and poor limits of 
detection due to a short optical path through the capillary for detection. 
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1.1.5 Cyclodextrins 
Cyclodextrins (CDs) are neutral and water soluble cyclic oligosaccharides of several 
glucopyranose units which can be used as chiral selectors. They are chiral due to the 
presence of asymmetric carbon atoms on the glucose units and glycosidic bridges 
between the glucose units. Figure 1.11 gives the structures of the three most widely 
used cyclodextrins. Cyclodextrins are named by the number of repeating glucopyranose 
units in their structure. α-CD has 6, β-CD has 7 and γ-CD has 8 glucose units. They are 
produced from the degradation of starch by the enzyme glycosyltransferase.15 The 
process involves the cleavage of a turn of the starch helix followed by intramolecular 
cyclisation.16 CDs have a characteristic truncated cone structure with a cavity of 
different dimensions depending on CD type (α being the smallest). The external surface 
of a CD is hydrophilic due to it containing hydroxyl groups, while its inner cavity is 
hydrophobic as it is lined with ether-like anomeric oxygen atoms. It is this cavity that 
makes CDs such useful tools, as they are capable of including guest molecules of 
different types, particularly those with non-polar groups. Among all the potential hosts 
available today, (e.g. dendrimers and crown ethers) cyclodextrins are significant, due to 
the following reasons:17 
• CDs are semi-natural products as they are produced from a renewable source 
(starch) by a relatively simple enzymatic conversion.  
• They are produced on an industrial scale (thousands of tons per year) by 
environmentally friendly technologies. 
• The scale of their production has reduced their initially high prices to a level 
acceptable for most industrial applications. 
• Their inclusion ability can be significantly altered by derivatisation and is 
already widely used in many industrial products, technologies and analytical 
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methods. Indeed worldwide there are 30-40 different drugs marketed as 
cyclodextrin complexes.18, 19, 20 
• Any of their toxic effects are of secondary character and can be eliminated by 
selecting the appropriate CD type or derivative.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11 Structures of a) α-CD, b) β-CD and c) γ-CD, viewed from the secondary hydroxyl group face 
1.1.6 Inclusion Complexes 
In aqueous solutions, the less polar cavity of cyclodextrins is occupied by water 
molecules. Due to polar-apolar interaction this is energetically unfavourable and in the 
presence of a less polar molecule the water molecules are replaced by the guest 
molecule. The most frequent and simplest host:guest ratio is 1:1. However 2:1, 1:2, 2:2 
and higher order equilibria can exist.17 The formation of the inclusion complexes can be 
described by the following thermodynamic equilibrium where G is the guest molecule,  
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CD + G CD.G  
                                                                 Equation 1.1 
 
p-xylene
+
CD p-Xylene CD Complex
 
Figure 1.12 Schematic representation of inclusion of p-xylene by CD; solvent is omitted for clarity 
It is the inclusion ability of CDs that is exploited in this work and more crucially their 
ability to discriminate between enantiomers. Native cyclodextrins however are poor 
chiral discriminating agents.21  Literature suggests that the presence of a metal ion 
centre, introducing further structural restrictions on any complex formed, can greatly 
enhance chiral discrimination particularly in the cases of some amino acids.22 However 
CDs are also inefficient coordinating ligands because of intramolecular hydrogen 
bonding.  This function can be enhanced by modifying the cyclodextrin which has the 
dual effect of increasing solubility and coordinating ability.23  
The choice of CD is a very important factor and is the first step in creating a chiral 
selector. This choice is essentially dependant on the enantiomers to be resolved. As the 
aim of this project is to investigate chiral selectors based on metallo-CDs for the 
separation of the enantiomers of tyrosine and DOPA, a cyclodextrin with the 
appropriate cavity size must be selected. If the cavity is too small no inclusion will be 
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possible and if the cavity is too large, it is reasonable to assume that the non-covalent 
bonds responsible for inclusion will not be strong enough to hold the guest in place.  
α-CD has been shown to include low molecular weight molecules or compounds with 
aliphatic side chains. β-CD can include aromatic compounds and heterocycles while γ-
CD is more suited to inclusion of macrocycles and steroids.24 β-CD was chosen as the 
ideal candidate in this work as its cavity dimensions are the appropriate size for the 
inclusion of benzene ring-based molecules.25 These dimensions are shown in Figure 
1.13 while Table 1.1 shows some of the physical properties of cyclodextrins.  
780 pm
1370 pm
570 pm
1530 pm
780 pm
1690 pm
950 pm
780 pm 780 pm
 
Figure 1.13 Cyclodextrin dimensions 
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Table 1.1 Physical properties of α-CD, β-CD and γ-CD 
----------------------------------------------------------------------------------------------- 
      α-CD  β-CD  γ-CD 
----------------------------------------------------------------------------------------------- 
Number of glucopyranose units  6  7  8 
Molecular weight (anhydrous)  972.85  1134.99 1297.14 
Solubility in H2O at room temp.  14.50  1.85  23.20 
(g/100 cm3) 
Annular diameter measured from  470  600  750 
the C5 hydrogens (pm) 
Annular diameter measured from  520  640  830 
the C3 hydrogens (pm) 
Annular depth from the primary to  ~800  ~800  ~800 
the secondary hydroxyl groups (pm) 
Annular volume, pm3   17400  26200  42700 
Partial molar volume (cm3 mol-1)   611.4  703.8  801.2 
[α]D at 25 °C     +150.5  +162.5  +177.4 
pKa at 25 °C    12.33  12.20  12.08 
 
1.1.7 Cyclodextrins and Metal Ions 
As metal ions behave as Lewis acids (electron pair acceptors), they have the ability to 
bond with a vast number of both organic and inorganic molecules. To facilitate this 
bonding one condition is that the molecules must have one or more electron pairs 
available for donation i.e. Lewis bases. The resulting species is called a coordination 
complex and the electron pair donors are called ligands.  The Irving-Williams series 
allows selection of a metal ion that forms the most stable metal-ligand complexes. From 
the series it is clear that Cu2+ has the highest stability constant and is therefore used in 
this work.26 
Mn2+< Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+ 
                    Increasing ionic potential and stability constant 
Figure 1.14 Irving Williams series 
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Cyclodextrins can behave as first sphere or second sphere ligands. They can also behave 
simultaneously as both first and second sphere ligands. It was Alfred Werner in 1893 
who proposed that the coordinating influence of many transition metal complexes 
extends beyond their covalently bound first sphere ligands to noncovalently bound 
species in the second sphere.27  
M
L
L
L
L
X
X
XX
1st
sphere
2nd
sphere
 
Figure 1.15 Representation of first and second sphere coordination where M is the metal ion, L is the first 
sphere ligand and X is the second sphere ligand 
Costes et al. demonstrated the first use of second sphere coordination by molecular 
receptors using crown ethers, which formed adducts with transition metal complexes 
containing aqua ligands.28 Crown ethers have also been shown to form adducts with 
transition metal amine complexes.29 In these complexes strong hydrogen bonds are 
formed between the oxygen atoms of the crown ether and the protons of the neutral first 
sphere ligands.  
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Figure 1.16 Second sphere coordination of a metal amine complex by 18-crown-6 where L = organic ligand 
and X = inorganic ligand 
Some of the earliest work on CDs as second sphere coordination ligands was carried out 
by Siegel and Breslow using CD-ferrocene coordination complexes.30 Harada and 
Takahashi also investigated crystalline samples of ferrocene and CDs and found that for 
α-CD a 2:1 complex was formed whereas β-CD and γ-CD each formed a 1:1 complex 
with ferrocene.31 (Figure 1.17) 
 
Fe Fe
Fe
a) b) c)
 
Figure 1.17 Proposed structures of ferrocene inclusion complexes of a) α-CD, b) β-CD and c) γ-CD using 
second sphere coordination 
Critical to the work reported here is the ability of cyclodextrins to act as first sphere 
ligands. CDs are inefficient first sphere ligands, but this can be improved by 
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deprotonation of the hydroxyl groups at high pH. Matsui et al. were the first to report 
the formation of a metal-CD complex with the metal ion coordinated directly to the 
cyclodextrin.32 Figure 1.18 shows the proposed binuclear hydroxyl-bridged structure for 
this complex. Nair and Dismukes prepared a complex of β-CD with Mn(III) with a 
Mn:CD ratio of 2:1.33 A bridged structure similar to that proposed by Matsui was 
supported by electronic and vibrational spectroscopy results.  
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Figure 1.18 Proposed binuclear bridged structure of the [Cu2(OH)2-β-CD]2- complex 
The possibility of simultaneous second sphere interaction in this complex was proposed 
by Stoddart and Zarycki.34 They postulated that hydrogen bonding could link the 
secondary hydroxyl groups of the CD with the hydroxyl groups of the bridged structure. 
This suggestion that cyclodextrins may act as both first and second sphere ligands 
simultaneously was supported by vibrational spectroscopy studies carried out by Russell 
and McNamara.35 Further studies from this group showed that similar complexes are 
formed by a range of metal ions with β-CD such as Mn(III), Cr(III), Fe(III), Co(II) and 
Cu(II).36  
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Modifying cyclodextrins can also allow them to act as first sphere ligands for metal 
coordination. These derivatised CDs have been used as metallo-enzyme mimics and as 
catalysts. Breslow and Overman prepared the nickel(II) chelate of an α-CD ester of 
pyridine-2,5-dicarboxylic acid (Figure 1.19).23 The electron donating nitrogen and 
oxygen atoms allow for the coordination of the metal ion. This derivative was further 
developed by Szejtli and Pagington resulting in “Breslow’s Enzyme” which increased 
the rate of hydrolysis of p-nitrophenylacetate over 1000-fold.37  
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Figure 1.19 Proposed structures of a) Ni(II) chelate coordinated to α-CD ester of pyridine-2,5-dicarboxylic 
acid and b) Breslow’s Enzyme 
Nitrogen-modified cyclodextrins have been reported to be particularly efficient ligands 
for first sphere coordination of various metal ions. Matsui et al. reported the synthesis 
of the 6-deoxy-6-[1-(2-amino)ethylamino]-β-cyclodextrin (CDEn) derivative which was 
shown to form a complex with Cu(II) at a pH of 10.5.38  Figure 1.20 shows the proposed 
structure of the complex. 
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Figure 1.20 Proposed structure of the Cu(II) complex with the diaminoethane-β-CD derivative CDEn 
Bonomo et al. showed that at a pH of 7.8 a 1:1 complex of CDEn and Cu(II) formed 
and that this complex displayed some enantiomeric stereoselectivity towards amino 
acids.39 Brown et al. reported similar selectivity using a range of metal centres (Co(II), 
Ni(II), Cu(II) and Zn(II)) with a diaminopropane derivative of β-CD, CDPn.40 Work 
previously carried out by this group demonstrated how the choice of metal centre can 
enhance the enantioselectivity of a hydroxylethylamine-CD derivative (CDea).41  
Therefore critical to this work is the selective modification of the primary hydroxyl 
group on the C6 position of β-CD to take advantage of the metal ion coordination 
properties of amino CDs. 
1.1.8 Functionalised Cyclodextrins 
There are many different functional groups, for example methyl and hydroxypropyl 
groups, which can be introduced onto the cyclodextrin molecule by reaction of the 
hydroxyl groups lining the upper and lower ridges of the toroid.  The result is a large 
number of possible positional and optical isomers since each hydroxyl group differs in 
its chemical reactivity and the resultant cyclodextrin products are amorphous.  
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Theoretically a cyclodextrin molecule can have up to 3(n) substituents, where n is the 
number of glucopyranose units that comprise the CD molecule.  This is called the 
degree of substitution (DOS) and refers to substituents other than hydrogen. 
Apolar Cavity
X (Primary Hydroxyl groups)
Y (Secondary Hydroxyl groups)
 
Figure 1.21 Cyclodextrin substituents 
Figure 1.21 shows substituent X, following the replacement of one C6 hydroxyl group 
whereas substituent Y involves replacement of one of the C2 or C3 hydroxyl groups.  
The multiple numbers of hydroxyls on cyclodextrins enables many possible 
modifications. This was highlighted in 1998 by Cyclodextrin News, which stated that 
more than 1500 new derivatives were reported from 1985 to 1997.42 
 
1.1.9  Modification Involving the C6 Primary Hydroxyl Group 
Selective modification of the C6 hydroxyl groups on the CD is assisted by the fact that 
the primary face of the torus suffers less steric hindrance than the secondary.  In 
addition there is less hydrogen bonding between the hydroxyls at C6 than those at C2 
and C3.  Also the primary hydroxyl groups of CDs are the most basic and most 
nucleophilic and can be selectively modified through reaction with an electrophilic 
species.  
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Amino derivatives of CDs can be prepared by an indirect approach. For example 
hemispherodextrins shown in Figure 1.22 have been reported by Cucinotta et al. These 
capped cyclodextrins namely, 6A,6D-dideoxy-6A,6D-[6,6’-dideoxy-6,6’-di(S-
cysteamine)-α,α’-trehalose]-β-CD (THCMH) 43, 6A,6D-dideoxy-6A,6D-N-[6,6’-di-(β-
alanylamino)-6,6’-dideoxy-α,α’-trehalose]-β-CD (THALA)44 and 6A,6D-(6,6’-diamino-
α,α’-trehalose)-6A,6D-dideoxy-β-CD (THAMH)45 which have been shown to be 
effective chiral selectors for amino acids using Capillary Electrophoresis were 
synthesised from the 6A,6D-dideoxy-6A,6D-diiodo-β-cyclodextrin intermediate. 
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Figure 1.22 Schematic structures of hemispherodextrins 
A more widely used intermediate is mono-6-deoxy-6-tosyl-β-cyclodextrin (CDTs).  A 
common method for preparation of CDTs involves reaction of β-CD with excess p-
toluenesulphonyl chloride, with recrystallisation from water.46 Due to the importance of 
these sulphonates acting as intermediates for the further synthesis of other modified 
CDs, there exist many other methods of preparation.47, 48, 49, 50  For instance CDTs can 
be prepared by the reaction of β-CD with p-toluenesulphonyl chloride in pyridine.48  
This route has the disadvantage that the product is obtained in poor yield and must be 
separated from multitosylated by-products by chromatography along with the inherent 
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difficulties of using pyridine as a solvent.  The synthesis used in this study is a slightly 
modified version of an aqueous-based method reported by Brady et al.49  
Monoamine derivatives of CDs have been prepared by the treatment of the 
corresponding tosylate with ammonia.46  Analogous reactions of primary and secondary 
amines have also been reported as a method for attaching amino groups at the C6 
position of a CD.51  These materials can then be exploited for further modification, 
since the amino groups are substantially more nucleophilic than the CD hydroxyl 
groups. Matsui et al. published a synthesis route for 6-deoxy-6-[1-(2-
amino)ethylamino]-β-cyclodextrin (CDEn) in 1976.38  A modified version of Matsui’s 
synthesis was also reported by Singh et al.52  The diaminoalkane derivatives 6-deoxy-6-
[1-(2-amino)ethylamino]-β-cyclodextrin (CDEn),  
6-deoxy-6-[1-(3-amino)propylamino]-β-cyclodextrin (CDPn) and 6-deoxy-6-[1-(4-
amino)butylamino]-β-cyclodextrin (CDBn), prepared here follow a modified synthesis 
of the route proposed by Singh et al.  
NH
NH2
NH NH
NH2
NH2
1 2 3  
Figure 1.23 Structures of  1) CDEn, 2) CDPn and 3) CDBn 
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1.2 Aims and Objectives 
In a review of charged CD derivatives, Cucinotta et al. have shown that functionalised 
cyclodextrins can be used as efficient chiral selectors for a range of enantiomeric 
species.53 Many cyclodextrin derivatives have been studied including anionic sulfated 
cyclodextrins (SCDs) and neutral or cationic amino-cyclodextrins (CDAm). However 
mechanistic studies are still required in order to determine a mode of action if these 
selectors. It has been suggested that anionic selectors are very effective due to 
electrostatic interactions with cationic analytes.54 It has also been suggested that binary 
metallo-CD complexes can act in a multi-site recognition manner, using the inclusion 
properties if the CD cavity in cooperation with the coordination ability of the metal 
ion.55  Therefore the aim of this work is to determine if copper(II) complexes of amino-
CD derivatives provide a more versatile solution than sulfated cyclodextrins for the 
direct separation of enantiomers in capillary electrophoresis. 
To this end the objectives of this work are as follows: 
1. Electronic Spectroscopy Study of Binary and Ternary Complexes. 
In chapter two the results of an electronic spectroscopy study of the metallo-complexes 
of the amino-cyclodextrins CDEn, CDPn and CDBn are presented. Electronic 
spectroscopy was used in order to determine if Cu(II) coordinates to the amino-CDs and 
to determine if further coordination to guest species such as tyrosine, DOPA, carbidopa 
and benserazide occurs. 
2. Circular Dichroic Study of Binary and Ternary Complexes. 
In chapter three the results of a circular dichroic (c.d.) spectroscopic study of the Cu(II) 
complexes of CDEn, CDPn and CDBn are presented. The formation of ternary 
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complexes with tyrosine and DOPA is also studied. c.d. spectroscopy can show the 
differential inclusion of enantiomers in cyclodextrin cavities and therefore was used 
here to determine if the metallo-cyclodextrins can act as chiral selectors for the 
enantiomers of tyrosine and DOPA. 
3. Stoichiometry of Binary and Ternary Complexes. 
The stoichiometry of the complexes formed by Cu(II) and CDEn, tyrosine, DOPA and 
carbidopa were investigated using Job’s method of continuous variation, and the results 
are presented in chapter four. 
4. Separation by Capillary Electrophoresis 
The chiral selector identified in the c.d. study was used in the background electrolyte to 
determine if it is a versatile and effective chiral selector for a range of separations. 
Chapter five details the development of a method for the separation of L-DOPA from L-
carbidopa along with a method for the chiral separation of the enantiomers of DOPA in 
a Chiral Ligand Exchange Capillary Electrophoresis experiment. 
Chapter six presents the conclusions arising from this work. The synthetic methods and 
characterisation techniques used in this work are summarised in chapter seven. 
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2. Electronic Spectroscopic Study of Binary and 
Ternary Complexes 
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2.1 Introduction 
The use of electronic spectroscopy in the detection of first sphere coordination of 
transition metal ions with cyclodextrins and their derivatives is well established.1, 2, 3 A 
shift in the maximum wavelength of absorption λmax indicates a change in the strength 
of the ligand while a change in intensity of absorption can give an insight into the nature 
of the electronic transition occurring and structural symmetry of the complex. This is 
particularly useful in this work as an increase in absorption intensity with respect to the 
aquated copper(II) ion, measured in terms of the molar extinction coefficient ε, indicates 
a lowering in symmetry of the coordination sphere of the metal ion. Furthermore a 
decrease in λmax indicates replacement of the aqua ligands in the copper(II) complex by 
stronger amino-cyclodextrin ligands (CDAm). Electronic spectroscopy is therefore 
employed to obtain an understanding of the coordination between transition metal ions 
and the cyclodextrin derivatives and guest molecules. 
Matsui et al. investigated first sphere metallo-cyclodextrin complexes using electronic 
spectroscopy and reported a shift in λmax from ~800 nm for the aqueous copper(II) ion to 
667 nm for the aqueous solutions of metallo-CD complex at pH 10.5.4    A binuclear 
hydroxy-bridged structure was proposed with two copper ions coordinated to the O2 
and O3 groups of adjacent glucopyranose units and bridged by two hydroxyl groups. 
Russell and McNamara also proposed a binuclear bridge structure through the use of 
FTIR and Raman spectroscopies.1  The proposed structure is given in Figure 2.1.  
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Figure 2.1 Proposed binuclear hydroxy-bridged structure of the [Cu2(OH)2-β-CD]2- complex 
Norkus et al. studied complexes of β-CD and copper as well as a range of other 
transition metals.5   They observed the failure of these complexes to form at an acidic or 
neutral pH.  Also reported was the formation of a light blue [CuCD(OH)2]2- precipitate 
in the pH range 8-10, whereas a dark blue solution and no precipitate was seen at a 
higher pH, the result of the formation of the Cu(II) binuclear hydroxy-bridged complex. 
All of these studies suggest that cyclodextrins have poor coordination properties that 
can be improved at high pH values due to deprotonation of the hydroxyl groups.  
Coordination can also be improved by derivatising the cyclodextrin. 
Matsui et al. reported the formation of a Cu(II) complex with the CD derivative 6-
deoxy-6-[1-(2-amino)ethylamino]-β-cyclodextrin (CDEn).2 Electronic spectroscopy was 
also employed for the characterisation of this complex at a pH of 10.5. There was an 
observed shift in λmax from ~800 nm to 570 nm and the authors suggested the formation 
of a 1:2 complex between the Cu(II) ion and CDEn at this pH (Figure 2.2).  
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Figure 2.2 Proposed structure of the diaminoethane-β-CD derivative coordinated to Cu(II) at high pH. 
Electronic spectroscopy has also been used to study the ternary complexes of metallo-
CDs with amino acids. Bonomo and Cucinotta et al. have shown the coordination of 
copper to various CD derivatives, such as CDEn, 3A,3B-dideoxy-3A,3B-diamino-
2A(S),2B(S),3A(R),3B(R)-β-CD (AB3NH2), and 6-mono-deoxy-6-[4-(2-
aminoethyl)imidazolyl]-β-CD (CDmh).6,7,9 The binary complexes were shown to form 
ternary complexes with various guest species. For example, Cucinotta et al. showed the 
coordination of CuAB3NH2 to tyrosine by a shift in the d-d transition of Cu(II) from 
656 nm for the binary complex to 625 nm for the ternary complex.9 Potter et al. also 
utilised electronic spectroscopy to verify coordination of a metal ion to CDAm 
derivatives such as CDEn, 6-deoxy-6-[1-(3-amino)propylamino]-β-cyclodextrin (CDPn) 
and 6-deoxy-6-[1-(4-amino)butylamino]-β-cyclodextrin (CDBn). Further coordination 
to guest species was also discussed.3 For example coordination of copper to CDEn was 
demonstrated by a hypsochromic shift in the d-d transition of copper from 810 nm to 
671 nm. A further shift (671 to ~635 nm) was observed when the ternary complex with 
tyrosine was formed through further coordination of the metal ion. The structure 
proposed for the ternary complex is shown in Figure 2.3.  
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Figure 2.3 Proposed CuCDEn(Tyr) structure 
In this work electronic spectroscopy is used to study the binary Cu(II) complexes of 6-
deoxy-6-[1-(2-amino)ethylamino]-β-cyclodextrin (CDEn), 6-deoxy-6-[1-(3-
amino)propylamino]-β-cyclodextrin (CDPn) and 6-deoxy-6-[1-(4-amino)butylamino]-
β-cyclodextrin (CDBn) and their ternary complexes with D,L- tyrosine (Tyr), 3,4-
dihydroxy-L-phenylalanine (L-DOPA), 3,4-dihydroxy-D-phenylalanine (D-DOPA), D,L-
serine-2-(2,3,4-trihydroxybenzyl)hydrazide (benserazide) and S-(−)-α-hydrazino-3,4-
dihydroxy-2-methylbenzenepropanoic acid (L-carbidopa). 
2.2 Theory 
At room temperature the majority of molecules will exist in their vibrational and 
electronic ground states. Upon the absorption of visible or ultraviolet (UV) radiation it 
is possible for electronic transitions from this ground state to a higher excited electronic 
state. Such transitions can only occur if the incident radiation corresponds in magnitude 
to the energy gap between these two states. This is given by the following relationship, 
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ΔE = Ef - Ei = hν = hc/λ     Equation 2.1 
where Ef and Ei are the energies of the final and initial electronic states respectively, h is 
Planck’s constant and v is the frequency of the radiation. λ is the maximum wavelength 
of absorption and c is the velocity if light.  
The absorbance (A) at λmax can be related to the molar extinction coefficient ε by the 
Beer Lambert Law: 
A = ε.c.l     Equation 2.2 
where c is the concentration of the absorbing species in mol dm-3 and l is the path length 
in cm. 
Pathways for the absorption of electromagnetic radiation by molecules and the 
corresponding return to the ground state can be illustrated using a Jablonski Diagram 
(Figure 2.4). 
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Figure 2.4 Jablonski diagram showing electronic absorption and emission 
The area of interest in this work is the electronic spectra of metallo-complexes, which 
show absorption bands occurring from a variety of electronic transitions including, 
• Transitions involving π, σ or n electrons of the ligands or counter ions. 
• Transitions involving charge transfer between metal and ligand orbitals or vice 
versa. 
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• Transitions between metal d orbitals, known as “d-d” transitions. 
As a result of selection rules charge transfer causes very intense absorption bands which 
occur at high energy usually in the UV region. On the other hand d-d transitions tend to 
give weaker and broader signals at lower energies from the near IR to near UV. The 
selection rules for these processes are the Laporte Rule and the Spin Forbidden Rule. 
• Spin Forbidden Rule:  
  
Transitions in which the total spin of the electrons remains fixed are spin allowed 
transitions i.e. ΔS = 0 where S is the total spin quantum number. Therefore there can be 
no change in the number of parallel electron spins, during the transition. 
• Laporte Rule:   
 
Transitions involving the redistribution of electrons within a single energy level are 
forbidden, i.e. s→p or p→d transitions are allowed but d→d transitions are forbidden. 
However relaxation of the Laporte Rule can occur. Any phenomenon which alters the 
symmetry of the d orbitals has the effect of relaxing the Laporte rule. In tetrahedral 
complexes d orbitals are in an asymmetric environment and therefore tetrahedral 
complexes have ‘built-in’ relaxation of the Laporte rule. In octahedral complexes the 
Laporte rule is relaxed by a vibronic mechanism. Vibrational coupling alters the 
symmetry of the d orbitals so that transitions are no longer purely d-d but rather d → 
partially d. The Laporte rule is also relaxed by changes in the symmetry of complexes. 
Therefore as the symmetry is reduced the Laporte rule is more relaxed and the 
extinction coefficient will increase.  
In this work we use electronic spectroscopy to determine if Cu(II) ions form binary 
complexes with CDAm derivatives and then further form ternary complexes with amino 
acids and drugs such as tyrosine, DOPA, benserazide and carbidopa. 
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2.3  Experimental 
Electronic spectra were measured at room temperature using a Perkin Elmer Lambda 
900 UV/Vis/NIR Spectrometer.  The spectrometer is a double-beam, double 
monochromator ratio recording system with pre-aligned tungsten-halogen and 
deuterium lamps as sources.  The wavelength range is from 175-3300 nm with an 
accuracy of 0.08 nm in the UV-visible region and 0.3 nm in the NIR region.  It has a 
photometric range of +/-6 in absorbance. Parameters used in this work were: Range: 
200-800 nm, Slit Width: 0.1 nm, Accumulation: 1. Spectra were taken using 10 mm 
quartz cells and 1 mm cells at higher wavelengths to compensate for molar extinction 
coefficients being smaller.  The resultant spectra were combined for analysis. 
Solutions used for recording the electronic spectra were as follows: 
• CD derivative and guest solutions were prepared by dissolution of the 
appropriate moiety (0.010 mol dm-3) in a KH2PO4/NaOH buffer that was made 
using 500 cm3 of KH2PO4 (0.100 mol dm-3) added to 347 cm3 of NaOH (0.100 
mol dm-3) and diluted to 1000 cm3 with deionised water to give a resulting pH of 
7.2. 
• Binary and ternary complex solutions were prepared by addition of 2 cm3 of 
aqueous CuSO4.5H2O (0.010 mol dm-3), 2 cm3 of the amino CD (0.010 mol dm-3 
in buffer) and 2 cm3 of the guest (0.010 mol dm-3 in buffer), when appropriate, 
to a 10 cm3 volumetric flask and dilution to the mark using the KH2PO4/NaOH 
buffer resulting in an overall complex concentration of 0.002 mol dm-3.   
• The ternary complex solutions containing tyrosine were made to 0.001 mol dm-3 
due to the poor solubility of tyrosine.  The concentration of CDAm and 
CuSO4.5H2O was adjusted accordingly. 
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2.4 Results 
Figure 2.5 shows the electronic absorption spectrum of the hexaquacopper(II) ion. 
Figure 2.6 shows the spectra obtained from the electronic spectroscopic study of the 
binary complexes of Cu(II) with CDEn, CDPn and CDBn at a pH of 7.2. Figures 2.7 to 
2.11 show the electronic spectra for the corresponding ternary complexes, with L and D 
tyrosine, L and D-DOPA and L-carbidopa as guest molecules. Table 2.1 summarises the 
data obtained. Spectra of amino CDs and guests are given in Appendix 8.1. 
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Figure 2.5 Electronic absorption spectrum of [Cu(H2O)6]2+  
 
  
 
Chapter 2  Electronic Spectroscopy 
41 
 
 
Wavelength (nm)
200 300 400 500 600 700 800
A
bs
or
ba
nc
e 
(a
.u
.)
0.0
0.2
0.4
0.6
0.8
1.0
400 500 600 700 800
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
671
254
a) b)1)
 
 
 
Wavelength (nm)
200 300 400 500 600 700 800
A
bs
or
ba
nc
e 
(a
.u
.)
0.0
0.2
0.4
0.6
0.8
1.0
250
a) b)
400 500 600 700 800
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
730
2)
 
 
Wavelength (nm)
200 300 400 500 600 700 800
A
bs
or
ba
nc
e 
(a
.u
.)
0.0
0.2
0.4
0.6
0.8
1.0
400 500 600 700 800
0.05
0.10
0.15
0.20
0.25
745
242
a) b)3)
 
 
Figure 2.6 Electronic absorption spectra of binary complexes of Cu(II) with 1) CDEn 2) CDPn 3) CDBn in a) 1 
mm cell and b) 10 mm cell 
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Figure 2.7 Electronic absorption spectra of the ternary complexes of L-Tyr with Cu(II) and 1) CDEn 2) CDPn 
and 3) CDBn in a) 1 mm cell and b) 10 mm cell 
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Figure 2.8 Electronic absorption spectra of the ternary complexes of D-Tyr with Cu(II) and 1) CDEn 2) CDPn 
and 3) CDBn in a) 1 mm cell and b) 10 mm cell 
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Figure 2.9 Electronic absorption spectra of the ternary complexes of L-DOPA with Cu(II) and 1) CDEn 2) 
CDPn and 3) CDBn in a) 1 mm cell and b) 10 mm cell 
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Figure 2.10 Electronic absorption spectra of the ternary complexes of D-DOPA with Cu(II) and 1) CDEn 2) 
CDPn and 3) CDBn in a) 1 mm cell and b) 10 mm cell 
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Figure 2.11 Electronic absorption spectra of the ternary complexes of L-carbidopa with Cu(II) and 1) CDEn 2) 
CDPn and 3) CDBn in a) 1 mm cell and b) 10 mm cell 
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Table 2.1 Electronic Absorption Data for Binary and Ternary Cu(II) Complexes at pH 7.2 
  Binary Complexes 
     λ (nm)                         ε (  mol-1 dm3 cm-1) 
[Cu(H2O)6]2+  810 25 
[CuCDEn]n+ 
 
 
 
671 
254 
69 
4557 
 
[CuCDPn]n+ 
 
 
 730 
250 
 
79 
3143 
 
[CuCDBn]n+  745 
242 
70 
2179 
 
 
Ternary Complexes 
λ         (ε) 
 nm (  mol-1 dm3 cm-1) 
 
Guest Cu(CDEn) Cu(CDPn) Cu(CDBn) 
L-Tyr 615 (72) 
249 (6861) 
225 (11878) 
652 (66) 
260 (4133) 
224 (12194) 
660 (66) 
265 (3977) 
224 (12877) 
 
D-Tyr 
 
607 (72) 
248 (6735) 
225 (14560) 
 
621 (81) 
265 (4283) 
224 (12847) 
 
649 (58) 
267 (3366) 
224 (12367) 
 
L-DOPA 
 
605 (69) 
450 (91) 
290 (4968) 
236 (10895) 
 
624 (55) 
443 (83) 
296 (5466) 
231 (13497) 
 
622 (57) 
444 (105) 
298 (5553) 
232 (12195) 
 
D-DOPA 
 
 
 
 
L-Carbidopa 
 
 
 
 
 
D,L- 
Benserazide 
 
599 (123) 
436 (179) 
288 (5250) 
234 (11680) 
 
610 (54) 
469 (100) 
294 (4965) 
249 (7765) 
234 (9385) 
 
- 
 
627 (46) 
447 (80) 
297 (5251) 
233 (11803) 
 
- 
450 (920) 
298 (3365) 
289 (3970) 
234 (7200) 
 
- 
 
631 (41) 
444 (83) 
297 (5641) 
234 (12229) 
 
- 
439 (520) 
299 (2600) 
290 (2950) 
236 (6850) 
 
- 
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2.5 Discussion  
2.5.1 Binary Complexes 
The spectra of the binary complexes of Cu(II) with the amino cyclodextrin derivatives 
all show a band in the visible region assigned to the d-d transition of the metal centre. 
Bands in the UV region are assigned to electronic transitions of the CD moiety.  The 
Cu(II) hexaqua ion [Cu(H2O)6]2+ has a d-d transition at ~ 810 nm. However for the 
binary complexes [CuCDEn]n+, [CuCDPn]n+ and [CuCDBn]n+ a hypsochromic shift can 
be observed in each case, to 671, 730 and 745 nm respectively, suggesting that the 
CDAm ligands are stronger than aqua ligands. The order in which the ligand field 
strength increases (CDBn < CDPn < CDEn) is significant as it indicates the shorter the 
diaminoalkane moiety the higher the field strength. Previous publications by our group 
also reported similar values.3 In all cases there is also an increase in the value of the 
molar extinction coefficient when compared to the value of 25 mol-1 dm3 cm-1 obtained 
for the Cu(II) hexaqua ion. This indicates a lowering in symmetry of the coordination 
sphere around the metal ion as expected for these complexes. There is very little change 
in the spectra in the UV region compared to spectra of the ligands alone, except for a 
slight broadening of bands. 
Matsui et al. observed a shift to 570 nm for the [Cu(CDEn)2]2+ complex at pH 10.5 
(Figure 2.2). 8  Cucinotta et al. reported a shift from 810 nm for the Cu(II) hexaqua ion 
to 656 nm at a pH of 7 for the Cu(II) complex of a 3A,3B-diamine-3A, 3B-dideoxy-β-
cyclodextrin (AB3NH2) where A and B represent adjacent pyranose units of β-CD.9  
Similar complexes of 6A,6B-diamino-6A, 6B-dideoxy-β-cyclodextrin (ABNH2) exhibit a 
shift in λmax to 680 nm.10  These authors suggested this could be due to coordination of 
the metal ion to two nitrogen atoms of the ligands which are shown in Figure 2.12.  
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Figure 2.12 Representations of AB3NH2 and ABNH2 and diagram representing the labelling system used for 
disubstituted derivatives by Cucinotta4 and Bonomo5 
The results in this work are obtained in aqueous solution and the complexes do not 
crystallise. Therefore structural information is not available from X-ray crystallography. 
However some structural information can be inferred by comparison with the electronic 
absorption data for other complexes that have been shown to have aminoalkane ligands 
acting in a bidentate manner. For example it is reported that the complex 
[Cu(en)2Cl2].H2O has two bands in its electronic spectrum at 667 nm and 535 nm.11 
Therefore the results obtained here suggest that the two nitrogen atoms of CDEn have 
replaced two water molecules and the octahedral coordination sphere of Cu(II) may be 
completed by aqua ligands. The decrease in λmax suggests that CDEn and CDPn are 
acting as bidentate ligands through this coordination via the two nitrogen atoms of the 
diaminoalkane moiety.  The decrease in λmax is much less for the [CuCDBn]n+ complex.  
It is possible that in this case the metal ion may only be coordinated to one of the 
nitrogen atoms, as the longer alkane chain prevents access to the other amino group. 
The structures proposed are given in Figure 2.13.   
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Figure 2.13 Proposed structures of the binary complexes of Cu(II) CDEn, CDPn and CDBn (aqua ligands are 
omitted for clarity) 
2.5.2 Ternary Complexes  
Ternary complexes are formed when the binary complexes react with guest species such 
as amino acids. The ternary complexes formed in this work again display characteristic 
bands in the visible region of their electronic absorption spectra synonymous with the d-
d transitions of the copper metal centre. Bands in the UV region are difficult to assign as 
transitions in this region are complicated by the presence of the guest molecules which 
also absorb in this region. By collecting absorption data separately for the guest 
molecules it is possible to identify bands due solely to their transitions. From these 
spectra (Appendix 8.1) it is possible to assign the bands at ~225 nm to a transition of 
tyrosine while the band at 250–265 nm is assigned to transitions of both the amino acid 
and the CDAm species. Again when DOPA is the guest species, bands at ~280 nm can 
be assigned to transitions of the drug while absorption in the ~ 235 nm region is 
assigned to transitions of both the drug and CDAm species. When using carbidopa as 
the guest species bands at ~ 280 nm can be assigned to transitions of the drug while 
absorption in the 230-250 nm is assigned to both the drug and CDAm species. 
For the ternary complexes of tyrosine, DOPA and carbidopa a further hypsochromic 
shift in the d-d absorption band is observed when compared to the binary complexes. 
For example the band at 671 nm for [Cu(CDEn)]2+ is shifted to 615 nm for 
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[Cu(CDEn)(L-Tyr)]n+. Again this suggests further coordination of the metal ion to the 
guest molecule. Coordination would most likely take place to the amine and carboxylic 
acid groups of the amino acid/drug as both contain oxygen and nitrogen atoms with lone 
pairs available for donation to the metal centre.      
The results obtained for tyrosine and DOPA agree with work carried out by this group 
previously.3 There are no other reported electronic spectroscopy studies of tyrosine 
interaction with CuCDPn and CuCDBn. However parallels can be drawn from similar 
work with other cyclodextrin derivatives. Cucinotta et al. reported λmax values for 
complexes of tyrosine and the copper complex of AB3NH2 at ~ 270 and 624 nm (ε = ~ 
4900 and ~ 207 mol-1 dm3 cm-1).9  Bonomo et al. report λmax values for the d-d 
transition between 598-616 nm for both L and D enantiomers of tyrosine with the Cu(II) 
complexes of ABNH2.7 The results presented here compare favourably with these 
authors.  
The spectrum for the ternary complex of L-carbidopa with CuCDEn shows a further 
hypsochromic shift in the visible region indicating further coordination of the metal 
centre to the carbidopa guest. However stable complexation with CuCDPn and 
CuCDBn was not achieved. Upon mixing the solutions containing these chiral selectors 
a green solution is formed initially, which quickly becomes brown and a yellow/brown 
precipitate is formed, which is likely to be copper(I) oxide. Electronic absorption data is 
collected immediately on formation of the green solution. However as these ternary 
complexes are not stable, CDPn and CDBn are deemed unsuitable as chiral selectors for 
separations involving carbidopa. 
To the best of the author’s knowledge there are no reports on the coordination of 
carbidopa to a metallo-cyclodextrin.  
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It was not possible to investigate the coordination of benserazide to any of the metallo-
cyclodextrin derivatives, due to the formation of a precipitate. It is therefore concluded 
that the chiral selectors [CuCDEn]n+, [CuCDPn]n+ and [CuCDEn]n+ are not appropriate 
for separations involving this drug. The formation of any precipitate during either an 
electrophoretic or chromatographic separation could block the columns and terminate 
the analysis. Pecanac et al. investigated the determination of L-DOPA in the presence of 
benserazide in the medication Madopar by UV spectrophotometric micro-
determination.12 This was accomplished by complexing DOPA with copper and 
measuring changes in transitions in the UV region. Pecanac suggested that there was no 
interaction between copper and benserazide at the concentrations found in the 
medication as the presence of benserazide did not interfere with the determination of 
DOPA in the study.  
2.6 Conclusion of Electronic Spectroscopy Study 
From the increase in the molar extinction coefficient seen in the spectra of the binary 
and ternary Cu(II) complexes of aminocyclodextrins as compared to the hexaqua 
complex [Cu(H2O)6]2+ it can be concluded that there is a lowering in symmetry of the 
first coordination sphere of the metal ion. There is also a decrease in λmax for the d-d 
transitions on coordination of the metal ion to the amino cyclodextrins (CDAm). The 
results suggest the formation of a CuCDAm binary complex with CDEn and CDPn 
acting as bidentate ligands coordinating to the metal ion through the two nitrogen atoms 
of the diaminoalkane. CDBn acts as a monodentate ligand coordinating through just one 
nitrogen on the diaminoalkane chain. A further blue shift on the introduction of a guest 
species to the system suggests a further coordination of the Cu(II) ion to the guest 
creating a ternary complex. This was observed for tyrosine and DOPA with all three 
chiral selectors and for [CuCDEn]n+ and carbidopa. No coordination was evident with 
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benserazide. This result suggests that the use of these metallo-CD derivatives for 
enantioselection may be guest specific.  
Very few regular octahedral (Oh point group) Cu(II) complexes exist due to Jahn Teller 
distortion of the d9 ground state. Jahn Teller theory states that any non-linear molecule 
with a spatially degenerate electronic ground state will undergo a geometrical distortion 
that removes that degeneracy. Therefore Cu(II) complexes are normally tetragonal 
which results in a slight splitting of the degenerate eg level resulting in two possible 
electronic transitions. For example [Cu(en)2Cl2] is assigned to the D2h point group and 
has a pseudo-octahedral structure which gives rise to two bands in the electronic 
absorption spectrum at 667 and 535 nm.11 Spectra of the ternary complexes of CuCDEn 
with DOPA and carbidopa as guests also show two bands in the visible region at 600-
610 and ~ 430-470 nm. This suggests highly distorted or pseudo-octahedral structures. 
However at this stage it is not possible to propose definite structures for these ternary 
complexes. Further information concerning the enantioselective properties of CuCDEn 
must be obtained (Chapter 3) and the stoichiometry of the complexes formed must be 
determined (Chapter 4).  
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3. Circular Dichroic Study of Binary and Ternary 
Complexes 
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3.1 Introduction 
The electronic spectroscopy study presented in the previous chapter showed that the 
copper(II) complexes of amino-CDs can form ternary complexes with tyrosine, DOPA 
and carbidopa. However electronic spectroscopy cannot be used to determine the chiral 
recognition properties of the metallo-CDs. Therefore the circular dichroic properties of 
the binary and ternary complexes were investigated.  
Circular dichroism (c.d.) is a form of spectroscopy based on the differential absorption 
of left and right circularly polarised light. It is used to examine the optical properties of 
molecules. The technique has been used for the characterisation of pharmaceuticals.  
For example Bowen et al. report its use as an “Alternative Method for Drug Analysis”, 
claiming that the method has advantages in its simplicity, speed and reproducibility.1  
The technique is ideally suited to the detection of an optically active material present in 
a mixture of impurities that show no optical activity. Examples of applications studied 
by Bowen’s group include the determination of opium alkaloids,2 cocaine3 and heroin.4 
Due to their chiral nature circular dichroism has been increasingly applied in the study 
of cyclodextrins. The method has found great use in the measurement of the extent of 
inclusion of a species within the cyclodextrin cavity.  Donzé et al. studied the inclusion 
of L-tryptophan with various CD derivatives.  Intensity changes in the spectra suggested 
the successful inclusion of the guest within the cavity of the CD derivatives, with 
increasing intensities for the different derivatives suggesting increasing degrees of 
inclusion.5  Impellizzeri et al. used c.d. spectroscopy as a complimentary technique to 
NMR spectroscopy to study a N-tert-butoxycarbonyl-β-alanylhistamine (Boc) group 
self-including within a CD cavity.6   Similar examples of c.d. spectroscopy used as 
evidence of inclusion are given by Ramusino et al.7 and Tarnai et al.8 
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Circular dichroism spectroscopy has also been applied to measurements involving 
metals and metal complexes. Czarnecki and Margerum showed the c.d. spectra of 
copper and nickel complexes of tetra- and pentapeptides with c.d. signals in the d-d 
transition range.  The authors concluded that the involvement of the metal centre in 
chelation or its location immediately adjacent to the asymmetric centre is not essential 
for the resulting c.d. peak.9 
Bonomo et al. used both electronic spectroscopy and circular dichroism to examine the 
ternary complexes of copper, CDEn and amino acids.10 This is of particular relevance to 
the work reported here. Bonomo reported no inclusion of the amino acid alanine in the 
CD, but inclusion of the aromatic amino acids phenylalanine and tryptophan was seen, 
with the L enantiomer demonstrating stronger c.d signals.  The same group studied other 
similar systems, for example the Cu(II) complex of the derivative 6-deoxy-6-N-(2-
methylaminopyridine)-β-cyclodextrin [Cu(CDampy)]2+ and the Cu(II) complex of a 
histamine monofunctionalised β-cyclodextrin [Cu(CDhm)]2+ with similar results.6  
Studies carried out by Corradini et al. using metallo-CDs, also found that no 
stereoselectivity was observed towards aliphatic amino acids, whereas enantiomeric 
discrimination was observed for aromatic amino acids.11 
It is for this reason that c.d. spectroscopy was chosen to study the inclusion of tyrosine 
and DOPA enantiomers within the cavity of the derivatised CDs. Carbidopa was not 
included in this study since only the L-enantiomer is commercially available. 
Benserazide was also excluded since the electronic spectroscopy study demonstrated 
that it does not form a ternary complex with the metallo-CDs.  
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3.2 Theory 
A light beam is made up of electromagnetic waves that oscillate in all possible planes 
perpendicular to its path. Polarised light is produced by passing normal light through a 
polarising material such as a Nicol prism (crystalline calcium carbonate) or the material 
Polaroid (iodoquinine sulphate embedded in nitrocellulose film). Linearly plane 
polarised light oscillates in one single plane passing along the path of propagation.  
Circularly polarised light consists of two linearly plane polarised electromagnetic waves 
that are superimposed at an orientation of 90º to each other, both with an identical 
amplitude and frequency and which are out of phase by π/2 (λ/4).  The resulting vector 
propagates in a full circle during each cycle, similar to the shape of a screw thread, as 
seen in Figure 3.1. Circular dichroism is the differential absorption of right and left 
circularly polarised light.  The absorption coefficients of the two circularly polarised 
components differ due to the fact that they travel through the medium at different 
velocities and hence are absorbed to differing degrees by the substance.  Circular 
dichroism can be measured as electronic circular dichroism in the spectral regions 
where electronic transitions occur (UV-Vis) or as vibrational circular dichroism in 
infrared spectral regions. All measurements made in this study are in terms of electronic 
circular dichroism. 
 
Wave 1
Wave 2
Circular Component
 
Figure 3.1 Generation of Circularly Polarised Light by Superposition of Electric Components of Two Linearly 
Polarised Light Beams with a Phase Difference of a Quarter Wavelength 
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Therefore at a given wavelength, 
     Equation 3.1 
where ΔA is the difference between the absorbance of left circularly polarised (AL) and 
right circularly polarised (AR) light.  Applying the Beer-Lambert law gives, 
         Equation 3.2 
where εL and εR are the molar extinction coefficients for left and right circularly 
polarised light respectively, c is the molar concentration and l is the pathlength in cm.   
Thus the molar circular dichroism (Δε) can be described as 
                    Equation 3.3 
Circular dichroism also causes another effect, called ellipticity.  As the absorptions of 
the left circularly polarised light and the right circularly polarised light are different, the 
light exiting the sample is now elliptically polarised. Ellipticity is given by the angle θ 
and is defined as the tangent of the ratio of the minor to major elliptical axis as shown in 
Figure 3.2.   
θ
ER + EL
ER - EL
 
Figure 3.2 Elliptically polarised light (purple) is composed of unequal contributions of right and left circularly 
polarised light 
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C.d. instruments measure the difference in absorbance and results are normally reported 
in degrees or millidegrees of ellipticity.  When θ is in degrees, 
    Equation 3.4 
   
 
and when θ is in millidegrees 
                                  Equation 3.5 
       
 
Combining equations (3.2) and (3.5) gives,  
                    Equation 3.6 
where θ is ellipticity (mdeg), c is molar concentration (mol dm-3) and l is the pathlength 
of the cell (cm). 
In this work c.d. spectroscopy is used to determine if the binary Cu(II) complexes of 
CDEn, CDPn and CDBn include the two enantiomers of the guests tyrosine and DOPA 
to varying degrees, with a view to using the binary complexes for enantiorecognition.  
3.3 Experimental 
Circular dichroic spectra were measured at 25 ºC using a Jasco J-810 
Spectropolarimeter.  The Jasco J-810 spectropolarimeter allows measurement of both 
circular dichroism and optical rotary dispersion. The system uses a 150 W air-cooled 
Xenon arc lamp as the light source and has an operating range from 163 to 900 nm with 
a wavelength accuracy of approximately 0.2 nm.  A NIR sensitive photomultiplier tube 
(PMT) allows measurements out to 1100 nm. Up to four channels can be acquired 
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simultaneously. Two channels have been incorporated for external signals such as 
temperature probes, pH meters etc. The internal signal can be chosen from circular 
dichroism or optical rotatory dispersion. 
Calibration of the c.d. instrument was performed with a 0.06 % w/v ammonium d-
camphor-10-sulfonate solution in water using a 1 cm cell.  The spectrum was recorded 
between 350-250 nm and a c.d. peak value of +190.4 mdeg at 291 nm was found, which 
agreed well with reported values.12  
Parameters used for the rest of the study were: Range: 900-200 nm, Sensitivity: 
Standard (100 mdeg), Data Pitch: 0.1-0.5 nm, Scanning Mode: continuous, Scanning 
Speed: 50 nm/ min, Response: 1, Bandwidth: 1 nm, Accumulation: 6-8. 
For the circular dichroic study, spectra were recorded from 900 to 350 nm using a 10 
mm cell and from 450 to 200 nm using a 1 mm cell, unless otherwise stated, since the 
molar extinction coefficients are smaller in the higher wavelength region.  The resultant 
spectra were combined for analysis.  It should be noted that the concentrations of the 
solutions used for the circular dichroism study were the same as those used for 
recording the electronic absorption spectra in Chapter 2. 
3.4 Results and Discussion of Circular Dichroic Study 
3.4.1 Binary Complexes 
Figure 3.3 shows the spectra obtained from the c.d. spectroscopic study of the binary 
complexes of copper and CDEn, CDPn and CDBn. Table 3.1 summarises the results 
obtained.  
Table 3.1 Results of the c.d spectroscopic study of CuCDEn, CuCDPn and CuCDBn 
Binary Complex λ (nm) Δε (mol-1dm3 cm-)1 
CuCDEn 680 0.040 
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529 -0.01 
 308 0.026 
 262 -0.207 
 223 0.275 
CuCDPn 615 0.035 
 296 0.762 
 250 -0.251 
 217 -0.030 
CuCDBn 381 0.001 
 288 -0.060 
 245 0.007 
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Figure 3.3 Circular dichroic spectra of Cu(II) with 1) CDEn 2) CDPn and 3) CDBn 
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The c.d. spectrum of [CuCDEn]n+ shows bands at  308 nm (0.026 mol-1 dm3 cm-1), 262 
nm (- 0.207 mol-1 dm3 cm-1) and 223 nm (0.275 mol-1 dm3 cm-1) while the spectrum of 
the [CuCDPn]n+ system contains bands in the UV region at 296 nm (0.762 mol-1 dm3 
cm-1), 250 nm (- 0.251 mol-1 dm3 cm-1) and 217 nm ( -0.03 mol-1 dm3 cm-1). The c.d. 
spectrum of the [CuCDBn]n+ system shows bands at 381 nm (0.001 mol-1 dm3 cm-1),  
288 nm (-0.060 mol-1 dm3 cm-1) and 245 (0.007 mol-1 dm3 cm-1). 
Corradini et al. assigned the c.d. band found in the spectra of the binary complexes of 
Cu(II) with CD derivatives at ~ 250 nm to charge transfer transitions from the two 
highest occupied π-orbitals of the CD moiety to the vacant copper(II) d-orbital.11  
However since CDAm ligands also give bands in this region, it is difficult to confirm 
assignments.  Therefore it is probably more appropriate to broadly assign bands in the 
UV region to some transition of the CD group.  The band in the visible region of the 
spectra is assigned to d-d transitions of the metal ion. 
The binary complexes [CuCDEn]n+ and [CuCDPn]n+ give c.d spectra showing a broad 
band in the visible region (~ 680 nm for [CuCDEn]n+ and ~ 615 nm for [CuCDPn]n+). 
However this band is not evident in the c.d spectrum of [CuCDBn]n+ most likely due to 
poor coordination of CDBn to the Cu(II) ion. This result confirms the results seen in the 
electronic absorption study which showed poorer coordination of CDBn acting as a 
monodentate ligand.  
3.4.2 Ternary Complexes 
As was the case in the electronic spectroscopy study, bands present in the UV region of 
the c.d. spectra of the ternary complexes are assigned to transitions of the CD moiety 
and the amino acids and bands in the visible region are due to d-d transitions of the 
metal ion. Therefore to investigate the inclusion of the guests in the CD cavity it was 
important to concentrate on bands in the UV region.    
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Figures 3.4-3.5 show the spectra for the ternary complexes of D/L-tyrosine and D/L- 
DOPA with CuCDEn, CuCDPn and CuCDBn at pH 7.2. Table 3.2 summarises the 
results obtained. 
Increases in Δε arise from an increase in the depth of inclusion of the aromatic ring of 
an amino acid within the CD cavity.10 Therefore the circular dichroic spectra of all 
complexes were compared by calculating ∆(∆ε) where ∆(∆ε) = |∆ε(D)| - |∆ε(L)|) at ~ 
228 nm for tyrosine and 250 nm for DOPA. Table 3.3 summarises the results obtained. 
Table 3.2 Spectral data for tyrosine and DOPA ternary complexes at pH 7.2 
 
Guest 
 
Ternary Complex 
λ (nm)  (Δε) (mol-1 dm3 cm-1) 
 
 
 
[CuCDEn]2+ 
 
 
[CuCDPn]2+ 
 
[CuCDBn]2+ 
 
D-Tyrosine  
 
 
228 (2.71) 
277 (-0.41) 
298 (0.22) 
 
 
228 (3.08) 
270 (-2.00) 
295 (-0.02) 
 
 
227 (2.85) 
269 (-1.15) 
299 (0.43) 
L-Tyrosine 
 
225 (-0.89) 
270 (0.45) 
298 (-0.05) 
 
227 (-2.44) 
270 (0.62) 
295 (-0.02) 
228 (-2.40) 
269 (0.97) 
299 (-0.24) 
 
 
D-DOPA 
 
 
L-DOPA 
 
 
251 (-3.93) 
295 (-1.33) 
 
251 (1.96) 
295 (1.30) 
 
250.4 (-3.8) 
295 (-2.76) 
 
250.4 (3.72) 
295 (2.82) 
 
249.6 (-3.14) 
295 (-2.52) 
 
249.6 (3.47) 
295 (2.65) 
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Figure 3.4 Circular dichroic spectra of ternary complexes of Cu(II) and  D-tyrosine in red and L-tyrosine in 
blue with 1) CDEn, 2) CDPn and 3) CDBn 
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Figure 3.5 Circular dichroic spectra of ternary complexes of Cu(II) and  D-DOPA in red and L-DOPA in blue 
with 1) CDEn, 2) CDPn and 3) CDBn 
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Table 3.3 Comparison of ∆(∆ε)  values in the UV region for the ternary complexes of CuCDAm with tyrosine 
and DOPA  
Guest [CuCDEn]2+ [CuCDPn]2+ [CuCDBn]2+ 
Tyrosine 2.54 0.69 0.45 
DOPA 1.97 0.08 0.33 
 
From the c.d spectra and the results presented in Table 3.3 it is very clear that CuCDEn 
has the most favourable enantioselective properties towards tyrosine. The signal 
observed at 228 nm shows a much higher value of Δε for the D-diastereomeric complex 
compared to the L-diastereomeric complex. This indicates that the D-tyrosine 
enantiomer is included to a much greater extent than the L-tyrosine enantiomer. This 
obvious difference in inclusion cannot be seen using [CuCDPn]n+ and [CuCDBn]n+. The 
∆(∆ε) values obtained in these two cases are approaching zero which suggests a similar 
level of inclusion of both enantiomers and no discrimination between them. Therefore 
of the three amino-CDs used in this work only [CuCDEn]n+ is an effective chiral 
discriminator for tyrosine.   
Bonomo et al. investigated the inclusion complexes of [CuCDEn]n+ with D and L-
phenylalanine which is structurally similar to tyrosine.10 These workers reported bands 
in the c.d. spectra for these complexes at 236 nm and 286 nm which compare to the 
values obtained here for tyrosine (228 nm and 270 nm). They calculated a ∆(∆ε) value 
of 0.39 which is lower than that calculated for tyrosine here indicating CDEn is more 
stereoselective towards tyrosine than phenylalanine. However in this work the ∆(∆ε) 
values were calculated from bands in the UV region whereas Bonomo et al. calculated 
them from bands in the visible region.  
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In a separate study Bonomo et al. investigated the inclusion complexes of tyrosine with 
a bifunctionalised CD.13 These workers reported a c.d. spectrum of the ternary complex 
of [Cu(A,BCDNH2)] with D,L-tyrosine with bands at ~ 230 nm and 270-275 nm. This 
mirrors almost exactly the equivalent spectrum of tyrosine with CDEn recorded in this 
work.  
Maccarrone et al. also used c.d. spectroscopy to study the inclusion complexes of 
various CuCDAm derivatives including CDEn with amino acids such as tyrosine.14 
However they found that the difference between the enantiomers in terms of Δε was not 
detectable. This result is surprising given the Δ(Δε) recorded in this work (2.54). Again 
this could be attributed to these values being calculated from the visible region of the 
spectra versus the UV region here.   
For DOPA, [CuCDEn]n+ is again the most effective enantioselector. A ∆(∆ε) value of 
1.97 was recorded which is slightly lower than the value for tyrosine. Again the D-
enantiomer shows preferential inclusion over the L-isomer. This decrease in ∆(∆ε) may 
be surprising as the only difference between tyrosine and DOPA is the presence of an 
extra hydroxyl group on the aromatic side-chain. However it is possible that because of 
this extra polar group the non-polar CD cavity is repelling the side-chain of DOPA, thus 
leading to a decreased depth of inclusion. Again [CuCDPn]n+ and [CuCDBn]n+ show 
virtually no selection properties for DOPA.  
3.5 Conclusion of Circular Dichroism Study 
The circular dichroic spectra of the complexes studied suggest host-guest formation 
between the metallo-cyclodextrins and tyrosine and DOPA, with the formation of 
diastereomeric ternary complexes.  Differences in intensity of the bands in these spectra 
suggest that the metallo-cyclodextrins are preferentially including one isomer and 
therefore can possibly be used for enantiomeric separation. 
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From the results obtained in this study, it can be shown that [CuCDEn]n+ is the most 
enantioselective material for both tyrosine and DOPA. This enantioselection of 
[CuCDEn]n+ results from the preferential inclusion of the D-enantiomer over the L-
enantiomer within the CD cavity. It is therefore proposed that [CuCDEn]n+ is acting as a 
multi-site enantioselector, utilising both the inclusion properties of the CD cavity and 
the coordinating ability of the Cu(II) ion. Cu(II) will have a tetragonally-distorted 
octahedral structure due to its d9 configuration and therefore structural restrictions 
imposed by coordination of the guest to the copper(II) ion inhibit inclusion in the case 
of the L-enantiomer. A possible structure is given below in Figure 3.6. However the 
stoichiometry of the complexes must be determined to support any proposed structures.  
HN
NH2
Cu HN
NH2
Cu
H2N
HO
O
O
[D-Tyrosine(CuCDEn)]
NH2
OH
O
O
[L-Tyrosine(CuCDEn]
1) 2)
 
Figure 3.6 Proposed structures of the diastereoisomers of 1) [Cu(CDEn)(D-tyrosine)]n+ and 2) [Cu(CDEn)(L-
tyrosine)]n+ showing enantioselective orientation 
In the case of [CuCDPn]n+ enantioselection may not be possible due to the structure of 
the 1,3-diaminopropane moiety. The longer alkane chain may be flexible enough to 
allow interaction of the aromatic units of both enantiomers with the cavity.  For 
[CuCDBn]n+ it is proposed that the length of the alkane chain prevents the 1,4-
diaminobutane moiety acting as a bidentate ligand, which again may facilitate inclusion 
of both enantiomers in the cavity. Therefore these results suggest that one CuCDAm 
derivative is not a one stop shop for enantioselection.   
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4. Stoichiometry of Binary and Ternary 
Complexes 
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4.1 Introduction 
As discussed previously in Chapter 2 enantioresolution by metallo-CDAm derivatives is 
dependent in the first instance on their ability to form ternary complexes with guest 
molecules, where the L and D isomers form diastereoisomeric complexes. To fully 
understand the types of complexes formed in these experiments, their stoichiometry 
must be assessed.    
Various methods for the determination of the stoichiometry of complexes of CDs have 
been explored including microcalorimetry,1 NMR spectroscopy2 and surface tension 
measurement.3 However Wiczk et al. describe electronic and fluorescence 
spectroscopic methods which are the most widely used.4 In this work electronic 
spectroscopy was utilised.  
Statistical evaluation of the data collected can be achieved using either a non-linear 
least-squares fitting method (Benesi-Hildebrand)5 or the continuous variation technique 
(Job’s Plot).6  Reports by G. Pistolis and A. Malliaris7 and O. Exner8 suggest that the 
Benesi-Hildebrand method is not reliable for the determination of the stoichiometry and 
equilibrium constants of reactions involving weak complex formation. G. Pistolis et al. 
surmise that the method is incapable of differentiating between 1:1 and 2:1 
stoichiometries.7 As these are the most likely stoichiometries of our derivatives this 
method was not considered fit for purpose. The Job’s plot has been used successfully by 
groups investigating CD complex formation and was therefore selected as the preferred 
method in this work.9,10 
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4.2 Theory 
Inclusion complex formation can be described by the equilibrium, 
     Equation 4.1 
where H is the host molecule, G is the guest and C is the inclusion complex. The Job’s 
method of continuous variation to calculate the stoichiometric quantities h and g 
involves measuring an observable property that is proportional to the concentration of 
product (e.g. UV-Vis absorbance) in a series of solutions of constant total molarity, with 
varying host to guest ratio. It is best to measure this absorbance at a wavelength where 
the product absorbs and not the reactants. If this is not possible it is feasible to 
mathematically adjust for the absorption of the reactants   
Experimentally a series of solutions is prepared each containing the same total number 
of moles of H and G but a different ratio. If it is assumed that the total number of moles 
of H and G is 1 and the number of moles of H in a given solution is x then the number 
of moles of G is 1-x. 
Therefore, 
 
 
 
 
If x < H then H is the yield limiting reagent (YLR) and [C] = x/H. A plot of [C] versus x 
for a series of solutions is linear with a positive slope. 
If x > H then G is the YLR and [C] = 1-x/G. A plot of [C] versus x for a series of 
solutions is linear with a negative slope.  
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The maximum amount of complex is produced at the value of x where the two lines 
intersect.  
Figure 4.1 shows a stylised example of a Job’s Plot showing a 1:1 complexation 
predominant at equilibrium. Here the maximum point of inflection of the curve is at x = 
0.5. If the predominant complexation was 1:2 then x = 0.33 would be the maximum. 
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[C
]
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Figure 4.1 Example of a Job's plot showing 1:1 stoichiometry11  
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4.3 Experimental 
Electronic spectra were measured at room temperature using a Perkin Elmer Lambda 
900 UV/Vis/NIR Spectrometer. Parameters used in this work were: Slit Width: 0.1 nm, 
Accumulation: 1. Spectra were taken using quartz cells of 10 mm path length. Solutions 
used for recording the electronic spectra were as follows: 
• Host:Guest studies of DOPA and carbidopa were performed using stock 
solutions of CuCDEn (0.002 mol dm-3) and DOPA or carbidopa (0.002 mol 
dm-3) dissolved in ammonium acetate buffer at  pH 6.8.  
• Due to its poor solubility, tyrosine was used in a lower concentration (0.001 
mol dm-3). The concentration of CuCDEn was adjusted accordingly. 
 
For the Job’s plots, absorbance data was recorded at 650, 670 and 450 nm for CDEn, 
DOPA and carbidopa respectively. New bands occur at theses wavelengths on 
formation of complexes with Cu(II) for these ligands. However no new band was 
observed on reaction of Cu(II) or CuCDEn with tyrosine. In this case a wavelength 
should be chosen where either the host or guest has no contribution to the absorption. 
250 nm was chosen as tyrosine shows very little absorbance at this wavelength. Any 
unwanted contribution to the overall absorbance can be subtracted mathematically.    
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4.4 Results  
4.4.1 Binary Complex of Cu and CDEn 
Figures 4.2 and 4.3 show the spectra and Job’s plot for the spectral titration of Cu(II) 
with CDEn using the continuous variation method. The concentrations of the solutions 
used and the absorbance data obtained are given in Table 8.2 in Appendix 8.2.  
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Figure 4.2 Spectral titration of Cu(II) with CDEn 
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Figure 4.3 Job’s plot from spectral titration of Cu(II) with CDEn 
Figure 4.2 highlights the hypsochromic shift occurring gradually as the Cu2+ ion 
coordinates to the amino groups of the CDEn molecule (as discussed in Chapter 2). The 
absorbance values at 650 nm were plotted against [Cu] / [Cu] + [CDEn] and results are 
shown in Figure 4.3. Theoretically the Job’s Plot should show two intersecting straight 
lines. However this is an idealised result and the curve shown above is more realistic. A 
best fit curve was fitted using Sigma Plot 11 ® and the maximum point extrapolated to 
the x axis gives a value of 0.53 which indicates a ratio of 1:1 for Cu:CDEn 
stoichiometry   Bonomo et al. calculated the same stoichiometry in 1993 using a 
potentiometric method.12  This is encouraging as potentiometric techniques are 
experimentally more complicated than spectral titrations.  Matsui et al. also fitted UV 
absorbance data to a Job’s Plot calculating a 1:2 Cu:CDEn complex.9 The difference in 
results can be attributed to the difference in pH at which the experiments were carried 
out. Matsui et al. obtained results at a pH of 10.5 and at this pH both amino groups on 
CDEn (pKa1 5.56, pKa2 8.9213) will be deprotonated which may facilitate 1:2 complex 
formation. The results reported here and by Bonomo et al. were obtained at pH 6.8 and 
pH 7 respectively.   
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4.4.2 Binary Complexes of Cu and D- and L-Tyrosine  
Figure 4.4 shows the spectra obtained from the titration of Cu(II) and D- and L-tyrosine 
respectively, along with the corresponding Job’s plots obtained using the continuous 
variation method. The concentrations of the solutions used and the absorbance data are 
given in Table 8.3 and Table 8.4 in Appendix 8.2.  
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Figure 4.4 Spectral titration and Job’s plots of Cu(II) with 1) D-tyrosine and 2) L-tyrosine  
The Job’s plots obtained from titration of Cu(II) with D-tyrosine and L-tyrosine both 
show inflection points at ~ 0.4. As shown in the case of CuCDEn above a value of 0.5 
indicates a 1:1 complex. A value of 0.33 would indicate a 1:2 complex. As the 
inflection points lie between these values it is reasonable to suggest the presence of both 
1:1 and 1:2 Cu:tyrosine complexes in equilibrium.  Coordination of the copper ion to 
tyrosine is likely to occur at the electron donating amino nitrogen and carboxylic 
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oxygen. 1:1 and 1:2 complexes of Cu:tyrosine are well known and are used as low 
molecular weight analogs of superoxide dismutase.14  1:2 complexes are formed by 
copper(II) bridging two tyrosine molecules giving a bis-amino acid complex 
[Cu(II)(Tyr)2]2+.15,16 
4.4.3 Ternary Complexes of D- and L-Tyrosine and CuCDEn 
Figure 4.5 shows the spectra obtained from the titration of CuCDEn with D- and L-
tyrosine along with the corresponding Job’s plots obtained using the continuous 
variation method. The concentrations of the solutions used and the absorbance data 
obtained are given in Table 8.5 and 8.6 in Appendix 8.2.  
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Figure 4.5 Spectral titration and Job’s plots of CuCDEn with 1) D-tyrosine and 2) L-tyrosine 
The Job’s plots presented in Figure 4.5 show inflection points at 0.5 and 0.47 for the 
spectral titration of CuCDEn with D- and L-tyrosine respectively. These results suggest 
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the formation of 1:1 complexes of [CuCDEn(Tyr)] which agrees with the proposals of  
Bonomo et al.  for similar complexes of CuCDEn with alanine, phenylalanine and 
tryptophan.    
4.4.4 Binary Complexes of Cu and D- and L-DOPA  
For enantioseparation to be successful the guest species must interact with both CDEn 
and the Cu(II) ion. Electronic spectroscopy studies of the ternary complexes of 
[CuCDEn(DOPA)]n+ showed a sequential shift to lower wavelengths in λmax of the d-d 
transition of copper as it coordinated to CDEn and then to DOPA. To verify this 
interaction the stoichiometry of Cu:DOPA was investigated. Figure 4.6 shows the 
spectra obtained for the titration of Cu(II) and D- and L-DOPA along with the 
corresponding Job’s plots obtained using the continuous variation method. The 
concentrations of the solutions used and the absorbance data are given in Table 8.7 and 
Table 8.8 in Appendix 8.2.  
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Figure 4.6 Spectral titration and Job’s plots of Cu with 1) D-DOPA and 2) L-DOPA 
The Job’s plots obtained from titration of Cu(II) with D-DOPA and L-DOPA both show 
an inflection point at ~ 0.60. As shown in the case of CuCDEn above, a value of 0.5 
indicates a 1:1 stoichiometry, but a value of 0.66 would represent a 2:1 complex. As the 
extrapolated value lies between these ratios, it is reasonable to suggest that both 1:1 and 
2:1 ratios of Cu:DOPA are present in equilibrium.  
DOPA is potentially a tetradentate ligand with four donor atoms including the amino 
nitrogen, the carboxylic oxygen and the two ortho phenolic hydroxy groups.17 The 
coordination of catechols such as DOPA, by metal ions was studied by J. E. Gorton and 
R. F. Jameson in the late 60s where they investigated the complexes of Cu and DOPA 
by potentiometric measurements.18 They found that when there was an excess of ligand 
present both 1:1 and 1:2 amino acid-like and pyrocatechol-like complexes formed i.e. 
coordination via N, O and catechol hydroxyl groups respectively.   
4.4.5 Ternary Complexes of D- and L-DOPA with CuCDEn 
Figures 4.7 shows the UV spectra of the continuous variation method for the D and L- 
[DOPACuCDEn]+ ternary complexes along with the resultant Job’s Plots. The 
concentrations of the solutions used and the absorbance data are given in Table 8.9 and 
Table 8.10 in Appendix 8.2. 
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Figure 4.7 Spectral titration and Job’s plots of CuCDEn with 1) D-DOPA and 2) L-DOPA 
Both Job’s plots for the spectral titration of CuCDEn and the enantiomers of DOPA 
indicate complexes in a ratio of 2:1 host-guest.  
Bonomo et al. studied the thermodynamic properties of CuCDEn with some amino 
acids, namely alanine, phenylalanine and tryptophan.12 To the best of the authors’ 
knowledge no stoichiometric study exists in the literature for the complexes of CuCDEn 
with DOPA. However as DOPA contains an amino acid-like functional group and is 
structurally similar to phenylalanine (differing only by the presence of two hydroxyl 
groups on the ortho phenolic ring) comparisons can be made. Bonomo showed that the 
ternary complexes of all three amino acids exist as a [Cu(CDEn)(AaO-)]+  species with a 
1:1 host guest ratio. 
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Therefore the results of this study suggest that the presence of the hydroxyl groups on 
the ortho phenolic ring of DOPA which gives the ligand its tetradentate character has 
resulted in the formation of a [(Cu(CDEn)2)DOPA] complex.  
4.4.6 Binary Complex of Cu and L-Carbidopa  
Figure 4.6 shows the spectra obtained for the titration of Cu(II) and L-carbidopa along 
with the corresponding Job’s plot obtained using the continuous variation method. The 
concentrations of the solutions used and the absorbance data are given in Table 8.11 in 
Appendix 8.2. 
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Figure 4.8 Spectral titration and Job’s plot of Cu with L-carbidopa 
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The Job’s plot representing the complex of carbidopa and copper is shown above with 
an inflection point of 0.54. As stated before a value of x = 0.55 would indicate a 1:1 
complex. The curve in the plot above is quite broad with a maximum only achieved 
with curve fitting. However the value obtained does suggest a 1:1 Cu:carbidopa 
complex. Carbidopa has many structural similarities to DOPA with O, O and N, O 
coordination available to the copper ion. There is also the possibility for N, N 
coordination with copper.  
4.4.7 Ternary Complex of L-Carbidopa and CuCDEn 
Figure 4.9 shows the UV spectrum and Job’s plot for the coordination of carbidopa to 
CuCDEn.  The concentrations of the solutions used and the absorbance data are given in 
Table 8.12 in Appendix 8.2. 
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Figure 4.9 Spectral titration and Job’s plot of CuCDEn with L-carbidopa 
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The Job’s plot from the spectral titration of CuCDEn with L-carbidopa shows a 
maximum at ~ 0.6, which indicates that both 1:1 and 2:1 complexes are present in 
equilibrium. As mentioned previously carbidopa has potentially five donor atoms and 
therefore it is possible that complexes with 1:1 and 2:1 stoichiometry may form.     
4.5 Conclusion of Stoichiometry Study 
Table 4.1 details the stoichiometries of the binary complexes obtained in this study and 
based on these results proposed structures are shown in Figure 4.10.  
Table 4.1 Stoichiometry results for the binary complexes of Cu(II) with CDEn, tyrosine, DOPA and carbidopa 
at pH 6.8 
Metal Ligand Stoichiometry 
Cu(II) CDEn 1:1 
Cu(II) D-tyrosine 1:1 and 1:2 
Cu(II) L-tyrosine 1:1 and 1:2 
Cu(II) D-DOPA 1:1 and 2:1 
Cu(II) L-DOPA 1:1 and 2:1 
Cu(II) L-carbidopa 1:1 
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Figure 4.10 Proposed structures of the Cu(II) complexes of tyrosine, DOPA , carbidopa and CDEn based on 
stoichiometry results (charges and water are omitted for clarity) 
Support for these proposed structures can be obtained from the spectra presented earlier. 
On addition of [Cu(H2O)6]2+  to solutions of CDEn, tyrosine, DOPA and carbidopa 
there is a hypsochromic shift in the d-d transition. This indicates coordination of the 
Cu(II) to a stronger ligand than water in each case. As nitrogen is present in all of the 
ligands studied and is a stronger donor than oxygen it is reasonable to assume that it is 
Chapter 4 Stoichiometry of Complexes 
 
88 
 
involved in coordination to Cu(II) in each case. The results of the Job’s plot for 
CuCDEn indicates a 1:1 complex of Cu:CDEn which compares favourably to work 
previously carried out by Bonomo et al.12   
Table 4.2 summarises the results of the stoichiometric study for the ternary complexes 
and based on these results proposed structures for the diastereomeric complexes of 
tyrosine are given in Figure 4.11.  
Table 4.2 Stoichiometry results for the ternary complexes of CuCDEn with tyrosine, DOPA and carbidopa at 
pH 6.8 
Host Guest Stoichiometry 
CuCDEn D-tyrosine 1:1 
CuCDEn L-tyrosine 1:1 
CuCDEn D-DOPA 2:1 
CuCDEn L-DOPA 2:1 
CuCDEn L-carbidopa 1:1 and 2:1 
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[L-Tyrosine(CuCDEn]  
Figure 4.11 Proposed structures of the diastereoisomers of 1) [D-tyrosine(CuCDEn)] and 2) [L-
tyrosine(CuCDEn)2] (charges and water omitted for clarity) 
Support for these structures can be obtained from electronic spectroscopy which 
indicated coordination to the metal centre via the nitrogen of the amine group and 
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oxygen of the carboxyl group of tyrosine. Circular dichroism also indicated a difference 
in inclusion between the two enantiomers, with D-tyrosine showing deeper inclusion 
into the CD cavity. Further support for this proposal can be obtained from Maccarrone 
et al. who proposed similar structures for the diastereoisomeric ternary complexes of 
tryptophan and CuCDEn.19     
The results of the stoichiometric study carried out here suggests the formation of a 2:1 
CuCDEn:DOPA ternary complex and therefore the structures shown in Figure 4.12 are 
proposed. 
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Figure 4.12 Proposed structures of the diastereoisomers of 1) [D-DOPA(CuCDEn)] and 2) [L-
DOPA(CuCDEn)2] (charges and water are omitted for clarity) 
As before these proposals are supported by the results presented earlier. For DOPA a 
hypsochromic shift in the absorption spectrum for the ternary complex with CuCDEn 
versus the binary complex indicated further coordination of DOPA to the metal centre. 
Again c.d. spectroscopy shows differential inclusion between the two enantiomers with 
results indicating D-DOPA is included more fully than L-DOPA.  
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Electronic spectroscopy also suggested coordination of L-carbidopa to CuCDEn via the 
carboxyl and amino groups. The stoichiometric study suggested the existence of both 
1:1 and 2:1 CuCDEn:L-carbidopa ternary complexes in solution. Due to the lack of a 
commercially available sample of D-carbidopa a circular dichroic experiment could not 
be carried out and therefore it is not possible to compare inclusion of the enantiomers in 
the CD cavity. However since the structures of DOPA and carbidopa are similar it is 
possible that the ternary complexes also have similar structures and therefore proposed 
structures for the carbidopa complexes are shown in Figure 4.13.  
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Figure 4.13 Proposed structures of the diastereoisomers of 1) [L-carbidopa(CuCDEn)] and 2) [L-
carbidopa(CuCDEn)2] (charges and water are omitted for clarity) 
In conclusion it should be noted that the results above using the Job’s method assumes 
that there is only one reaction at equilibrium. This may not always be the case. There 
may be many competing metal-ligand reactions taking place. A more rigours study 
therefore needs to be carried out using speciation and potentiometric studies.   
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5. Separation of Enantiomers by Capillary 
Electrophoresis 
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5.1 Introduction  
Electrophoresis is the movement of electrically charged particles or molecules in a 
conductive medium (usually aqueous) under the influence of an electric field.1 Capillary 
electrophoresis (CE) describes a family of electrophoretic techniques that employ the 
use of a narrow tube or capillary. The system is a very simple concept but an extremely 
powerful technique that facilitates the separation of a wide variety of compounds. 
Initially CE as a technique was not very popular due to limitations with detection 
systems. However modern day CE instruments have overcome these initial problems 
and CE is now a versatile technique that offers high speed, high sensitivity and low 
limit of detection. Analytical chemistry has seen a major increase in the study of the 
separation of enantiomers and the number of papers published in this area, using CE has 
exponentially increased in recent years.2  
Just as HPLC has different modes, such as reversed phase and ion exchange, CE also 
has distinct modes of operation. The most common CE modes used are: 
• Capillary zone electrophoresis 
Capillary zone electrophoresis (CZE) is the simplest form of CE and separates analytes 
based on their mass to charge ratio. The separation relies mostly on pH-controlled 
dissociation of acids or protonation of basic groups on the analyte. 
• Electrokinetic chromatography 
Electrokinetic chromatography (EKC) is a family of electrophoresis techniques named 
after electrokinetic processes including, electroosmosis, electrophoresis and 
chromatography.  An example of EKC is cyclodextrin mediated-EKC (CD-EKC). 
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Separation occurs due to the differential interaction of enantiomers with CDs present in 
the background electrolyte (BGE) or buffer allowing for enantiomeric separation. 
• Micellar electrokinetic chromatography 
Micellar electrokinetic chromatography (MEKC) is another mode of EKC in which 
surfactants are added to the BGE to form micelles. Separation is based on the 
differential partition of analytes between the micelle and solvent. MEKC is very useful 
for separating mixtures containing both ionic and neutral species.   
• Capillary gel electrophoresis 
Capillary gel electrophoresis (CGE) is an evolution of traditional gel electrophoresis. It 
incorporates a polymer into the capillary to create a molecular sieve. This allows 
analytes with similar mass to charge ratios to be separated by size. The technique has 
been employed for the analysis of proteins and DNA sequencing and genotyping. 
• Capillary isoelectric focusing 
Capillary isoelectric focusing (CIEF) allows the separation of amphoteric molecules 
such as proteins by electrophoresis in a pH gradient generated between the anode and 
cathode. The analyte will migrate to a point in the capillary where its net charge is zero. 
Once the sample has been focused into a band it is pushed past the detector using 
pressure.  
• Capillary isotachophoresis 
Like isoelectric focusing, capillary isotachophoresis (CITP) relies on zero 
electroosmotic flow. The capillary is filled with a leading electrolyte that has a higher 
mobility than any of the sample components to be determined. Then the sample is 
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injected. A terminating electrolyte occupies the opposite reservoir, and the ionic 
mobility of that electrolyte is lower than any of the sample components. Separation will 
occur in the gap between the leading and terminating electrolytes based on the 
individual mobilities of the analytes. Both anions and cations can be determined, though 
not in the same run. 
• Non-aqueous capillary electrophoresis 
Non-aqueous capillary electrophoresis (NACE) separates analytes in a medium 
composed of organic solvents. The viscosity and dielectric constants of organic solvents 
affect the analyte mobility and also the electroosmotic flow allowing separation.  
 
As with HPLC there are two methods in CE for the separation of enantiomers, indirect 
and direct separation. Indirect separation in CE closely mirrors that of HPLC, with the 
use of chiral derivatisation agents before separation to form diastereomeric derivatives 
that differ in their physical and chemical behaviour. Thorsen, Engstrom and Josefsson 
reported the use of (+) and (-)-1-(9-anthryl)-2-propyl chloroformate as a chiral 
derivatising agent for the separation of amino acids and small peptides in 1997.3 
Kleidernigg and Lindner reported the use of (1R,2R)-N-((2-isothiocyanato)cyclohexyl)-
6-methoxy-4-quinolinylamide) as a fluorescence tag for the separation of amino acids 
and chiral amines.4  
Cyclodextrins are the most frequently used chiral selectors in CE and they allow for the 
direct separation of enantiomers. Snopek et al. reported the first application of CDs for 
the separation of enantiomers using capillary isotachophoresis (CITP) in 1988.5 
Guttman et al.6 used β-CD incorporated in capillary gel electrophoresis (CGE) and 
Fanali7 published the first paper dealing with the use of CDs in capillary zone 
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electrophoresis (CZE). However it is CD-EKC and a related mode Chiral Ligand 
Exchange CE (CLECE) in particular that applies to this work and will be discussed in 
greater detail later. Before this it is important to understand the mechanism of separation 
in CE.  
5.1.1 Separation Mechanism 
The separation mechanism in capillary electrophoresis is based on electrophoretic 
mobility and electroosmotic flow. Electrophoretic mobility (µ) is the movement of 
charged species in a fluid due to an applied electric field and is defined according to the 
equation, 
 
     
Equation 5.1 
where μ is the ion velocity, q is the charge, r is Stokes Radius of the ion and η is the 
viscosity of the solution. Therefore charged solute molecules are separated due to 
differences in their charge or electrophoretic mobilities and will migrate towards the 
electrode of opposing charge. Without the presence of a background electrolyte (BGE), 
negatively charged anions would migrate to the anode and into the source vial. However 
the BGE, because of its electroosmotic flow (EOF) carries them along to the detector.  
The EOF of the BGE is the motion of BGE through the capillary caused by the 
application of an electric field. Generally the direction of the EOF is towards the 
cathode so that the BGE will flow from the source to the destination vial. 
Electroosmotic flow has a relatively flat profile when compared to a laminar flow in 
HPLC. This is due to the frictional forces solutes experience in both techniques. In CE, 
frictional drag causes the EOF at the wall of the capillary to flow at a slightly lower rate 
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than through the rest of the capillary. This reduction in flow is quite small as the area 
near the wall of the capillary is very small. This flat or electrodynamic flow profile 
offers many advantages such as all solute molecules experience the same velocity 
regardless of position in the capillary cross-section and samples elute as narrow bands 
giving narrow peaks. This is in contrast to solutes in HPLC moving through columns 
under the influence of a pumping system. Solutes at the centre of the column move at a 
faster rate than those nearer the column wall. This uneven flow profile, shown below in 
Figure 5.1, leads to a higher degree of band broadening and relatively broad peaks in 
HPLC.1  
 
Electrodynamic Flow
Laminar Flow  
Figure 5.1 Electrodynamic and laminar flow profiles 
Most surfaces possess a negative charge which results from the ionisation of the surface 
or the adsorption of ionic species. In fused silica capillaries both processes occur and 
this results in the inside wall being extremely negatively charged. As the walls of the 
capillary are negatively charged, a layer of cations builds up near the surface to 
maintain the charge balance. This creates a double layer of ions near the surface and a 
potential difference known as the zeta potential.  
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Capillary wall with dissociated 
silanol groups
Stern Layer Diffuse Layer  
Figure 5.2 Schematic representation of the electric double layer 
Figure 5.2 gives a representation known as the Stern model of the electric double layer, 
showing that the double layer is made up of two sections. The first part has the 
approximate width of one ion, which is almost fixed to the surface of the capillary. The 
second part as the name suggests is diffuse and extends into the liquid. When an electric 
field is applied, the cations in the mobile diffuse layer are pulled towards the negatively 
charged cathode. As these cations are solvated they “drag” the bulk BGE solution with 
them, causing electroosmotic flow towards the cathode. Therefore positively charged 
analytes will also migrate towards the cathode. Negatively charged analytes will migrate 
towards the cathode, despite being attracted towards the anode because the EOF of the 
BGE is greater than the electrophoretic mobility of the anions. Neutral molecules are 
not influenced by electrophoretic mobilities as they carry no charge and therefore they 
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move through the capillary at the same rate as the EOF. Figure 5.3 shows the order of 
migration in CE and Figure 5.4 shows an idealised electropherogram. 
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Figure 5.3 Order of migration in CE  
 
Detector
Response
Migration Time
0
Cation
Neutral
Anion
 
Figure 5.4 Idealised electropherogram in normal polarity mode 
 
5.1.2 Capillary Electrophoresis Instrumentation 
The main components of a CE system are:  
• Sample vial 
• Capillary (typically fused silica externally coated with a polyimide layer) 
• High-voltage power supply (0 to +/-30kV) 
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• Detector 
• Source and destination vials 
• Data handling system 
Power Supply
Data Handling System
Detector
Source
Capillary
Anode + Cathode -
BGE Sample BGE
 
Figure 5.5 Capillary electrophoresis system schematic 
5.1.3 Sample Introduction 
Capillary electrophoresis is a microchemical method, as the capillaries used typically 
have a total volume of nanolitres to microlitres, which therefore requires a very precise 
and accurate sample introduction method.  
Various sample introduction methods exist for capillary electrophoresis including, 
hydrostatic, electrokinetic and hydrodynamic. A hydrostatic injection relies on a 
pressure difference induced by raising the sample end reservoir above the detection end 
reservoir. This difference in pressure forces the analyte into the capillary. To end the 
injection process the capillary is removed from the sample vial and placed in a BGE 
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reservoir. To calculate the volume of analyte introduced into a capillary (Vinject) using 
this injection method, the following equation is employed.8  
 
  
 
 
 
 
Equation 5.2 
 
where ρ is the BGE density, g the gravitational force constant, Δh the difference in 
height between the two reservoirs, η is the BGE viscosity, tinject  the injection time, r the 
radius of the capillary and L the length of the capillary.9  
Electrokinetic injections are generally simpler to perform than either the hydrostatic or 
hydrodynamic methods and they rely on the principles of electrophoretic and 
electroosmotic movement. The capillary tip is dipped into the sample vial, a potential is 
applied for a few seconds and the capillary is then placed in a BGE vial. As this 
technique is driven by the electroosmotic flow (EOF) and electrophoretic mobility of 
the analyte, analytes with the highest electrophoretic mobility will be preferentially 
introduced over those with lower mobilities.10 The following equation is used to 
estimate the electrokinetic injection volume, Vinject8 
 
 
Equation 5.3 
where Einject is the injection potential, Eseparate the separation potential, tinject the time of 
injection, tretention is the retention time of the analyte and Vcapillary is the volume of the 
capillary.  
There are several techniques that may be employed in hydrodynamic injection, such as 
pressure injection. Pressure injections can be achieved by placing the inlet of the 
capillary into a sample vial and applying a pressure to the vial. The volume of sample 
injected (Vinject) can be calculated using the Poiseuille equation, 
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    Equation 5.4 
where ΔP is the pressure across the capillary, r is the radius of the capillary, t is the time 
the pressure is applied, η is the viscosity of the sample and L is the total capillary 
length.  
5.1.4 Detection 
Detection in CE is very similar to that of HPLC, in that separated samples elute from 
the capillary in solution and the most widely used detection systems are UV-Vis 
absorption, fluorescence, laser-induced fluorescence and mass spectrometry. UV-Vis 
absorption detection was used in this work and a schematic representation of the diode 
array system is given in Figure 5.6.  
 
Deuterium Lamp
Slit Capillary Fixed Grating
Diode Array
Detection
Window
 
Figure 5.6 UV-Vis absorption with a diode array detector in CE 
White light of all UV-Vis wavelengths is generated by a deuterium lamp and passes 
through a window in the protective covering of the capillary and onto a grating that 
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diffracts the light into different wavelengths. The light then falls onto an array typically 
containing 200-500 diodes. Like a HPLC diode array detector wavelengths are selected 
by electronically sampling signals from the appropriate diodes. This allows for 
quantitative (electropherograms) and qualitive data, as well as peak purity and peak 
identification through stored libraries to be obtained. One attractive feature of UV-Vis 
absorption detection is that it is a non-destructive method, allowing for further analysis 
of the sample solution by other detectors placed downstream on the capillary. 
5.1.5 Chiral Ligand Exchange Capillary electrophoresis  
Chiral Ligand Exchange CE (CLECE) is related to Electrokinetic Chromatography 
(EKC). EKC separation is based on both electrophoretic migration and chromatographic 
separation and results from the partitioning of the analyte within pseudo phases with 
different effective mobilities. Many types of molecules can be used as pseudo phases or 
phase additives with micelles, crown ethers and cyclodextrins being the most popular.  
The ability to include guest molecules and their inherent chirality make cyclodextrins an 
excellent choice as chiral mobile phase additives (CMP). Anionic sulfated cyclodextrins 
are useful as CMP additives due to interactions with cationic analytes. With metallo-
cyclodextrins adding the coordination properties of a metal centre to the inclusion 
ability of the cavity gives a multi-modal chiral selector enhancing the enantioselective 
properties. This is analogous to enzyme systems which often contain metal centres.  
The exploitation of ligand exchange in liquid chromatography dates back to the early 
1960s, when Helfferich achieved separation by binding a metal ion to a cationic 
exchanger, resulting in the first ion exchange columns.11 However it was not until 1985 
when a ligand exchange process was first used in capillary electrophoresis. Grassman et 
al. used a BGE containing a copper(II) ion bound to two histidine molecules to separate 
the racemates of some α-amino acids.12 It took 18 more years for the first paper to be 
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published on the use of metallo-CDs and CE in a chiral ligand exchange separation. In 
2003 Cucinotta et al. synthesised an imidazole-bound histamine CD derivative and used 
it to separate the enantiomers of tryptophan in the presence of copper(II) ions.13  
Cucinotta et al. detail the following criteria which must be fulfilled for a CLECE 
separation to be successful: 14 
• The analyte and metallo-CD must form a ternary complex in solution. 
• The rate of ternary complex formation must be fast. 
• There must be a structural difference in the ternary complexes of the two 
enantiomeric analytes. 
• The ternary complex and free analyte must have different electrophoretic 
mobilities. 
The results of the electronic spectroscopy and circular dichroism studies presented 
earlier have suggested that the first three of these criteria have been met by the metallo-
CDs in this work. UV-Vis spectroscopy showed coordination of copper(II) to CDEn by 
a hypsochromic shift in the d-d transition band. A further shift in λmax indicates 
subsequent coordination of tyrosine, DOPA and carbidopa to this binary system, 
creating ternary complexes. The rate of ternary complex formation is high as the colour 
change occurred immediately on mixing the solutions. Differences in the depth of 
inclusion of each enantiomeric pair of analytes was seen using circular dichroism 
spectroscopy. 
For the ternary complexes and free analytes to have different electrophoretic mobility, 
they must carry different charges. It is possible to predict the average net charge of the 
analytes under investigation at a particular pH using the dissociation constants of the 
various functional groups (pKa values). As an amino acid tyrosine contains both an 
amino and a carboxyl group, making it both an acid and a base. Usually the structure 
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shows both the acidic and basic groups within the same molecule but these groups react 
with each other to form a dipolar ion known as a zwitterion which has no net charge. 
This is shown for the simplest amino acid, alanine in Figure 5.7. 
H3C C
H
NH2
COOH H3C C
H
NH3+
COO-
a) b)
 
Figure 5.7 Structure of alanine in the a) unionised form and b) zwitterionic form 
Therefore in aqueous solution amino acids can act as proton donors or proton acceptors. 
All amino acids are weak polyprotic acids due to the –COOH and –NH3+ groups and 
DOPA and carbidopa behave in a similar manner. The Henderson-Hasselbalch equation 
(Equation 5.5) can be used to determine the ratio of the concentrations of an 
undissociated acid (RCOOH) and its conjugate base (RCOO-) at a particular pH. 
If the dissociation equilibrium is written as;  
RCOOH + H2O ⇌ RCOO- + H3O+ 
then the Henderson-Hasselbalch equation is; 
 
 
 
Equation 5.5 
 
 
Rearranging gives; 
 
 
 
 
Equation 5.6 
 
Taking tyrosine as an example and using the pKa of the carboxyl group (2.20), 
substitution into equation 5.6 at the pH of the experiments (6.8) gives; 
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Therefore at pH 6.8, the carboxylic acid group of tyrosine is effectively ionised and in 
the form of RCOO-. 
Using the pKa of the RNH3+ group (9.11) and given the equilibrium; 
RNH3+ + H2O ⇌ RNH2 + H3O+ 
then  
 
 
Therefore at pH 6.8 the amino group of tyrosine is present as RNH3+. Similarly the side 
chain of tyrosine at pH 6.8 is present as ROH. Combining these calculations shows that 
at pH 6.8, tyrosine is present in the zwitterionic form.  
The net charge on an amino acid can also be estimated from the isoelectric point (pI) 
which is the pH at which most of the molecules in solution have a net charge of zero. pI 
can be found from the titration curve of the amino acid. The acid dissociation equilibria 
of tyrosine and a theoretical titration curve are given in Figures 5.8 and 5.9 respectively.  
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Figure 5.8 Acid dissociation equilibria for tyrosine 
 
Figure 5.9 Theoretical titration curve for tyrosine 
Structure two above shows tyrosine with a net zero charge and therefore from the 
titration curve the isoelectric point (pI) is halfway between the pKa values for the 
carboxyl and amino group. 
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Since the pH of the experiments in this work (6.8) is ~ 1 log unit above the pI, only a 
very small amount of the –NH3+ group has dissociated and the majority of the molecules 
are present as the zwitterion. 
The acid dissociation equilibria for DOPA and carbidopa are given in Figures 5.10 and 
5.11.  
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Figure 5.10 Acid dissociation equlibria for DOPA 
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Figure 5.11 Acid dissociation equilibria for carbidopa 
From the above equilibria, the pI of DOPA can be calculated as 5.50 (1/2(2.3+8.71)) 
and the pI of carbidopa as 8.01 (1/2(7.3+8.71)). The pH of 6.8 in this work is only ~ 1 
log unit above the pI of DOPA. Therefore only a small fraction of the –OH groups has 
dissociated and most of the DOPA molecules are zwitterionic. For carbidopa the pH is ~ 
1 log unit below the pI and therefore only a small fraction of the –NH group is 
protonated. Again most of the carbidopa molecules are zwitterionic. Bonomo et al. have 
studied the coordination properties of CDEn towards Cu2+ and have shown that at the 
pH used in this work the most stable species is [Cu(CDEn)]2+.15  
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Combining the results of these calculations with the results obtained in the electronic 
spectroscopy, c.d. spectroscopy and stoichiometry studies leads to the structures of the 
ternary complexes shown in Figure 5.12. 
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Figure 5.12 Structures at pH 6.8 of the proposed ternary complexes 
Comparing the structures of the analytes and their ternary complexes shows that they 
have different charges which should result in different electrophoretic mobilities. 
Therefore all the criteria for separation by CLECE to be theoretically possible have 
been met for CuCDEn and all three guest analytes.  
5.1.6 Separation of DOPA and Carbidopa 
There are few CE based methods available in the literature for the separation of the 
components of anti-Parkinson’s medications. Fanali et al. described the use of CZE for 
the separation of L-DOPA, carbidopa and benserazide.16 Using various BGE it was 
discovered that L-DOPA and benserazide could be separated between pH 2.5-7.0. L-
DOPA and carbidopa could only be separated at pH 8.5. However a mixture of the three 
analytes was not resolved even when BGE additives such as CDs, sodium dodecyl 
sulphate, organic modifiers and polyvinyl propylene were utilised. As anti-Parkinson’s 
medicines only contain L-DOPA and either carbidopa or benserazide, a scenario 
whereby all three analytes would need to be separated is unlikely to arise. However it is 
important to note that this is another example of how one universal method for 
separating chiral or structurally similar analytes does not exist. Saraç et al. screened 
various cyclodextrin derivatives for the separation of D,L-DOPA and D,L-carbidopa.17 
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Baseline separation of the enantiomers of DOPA was achieved using the single isomer 
heptakis(2,3-diacetyl-6-sulfato)-β-cyclodextrin (HDAS-β-CD) and sulfobutyl ether-β-
cyclodextrin (SBE-β-CD) at a pH of 2.5. The resolution and peak widths using SBE-β-
CD were found to be poor and resulted in poor sensitivity. D,L-Carbidopa was baseline 
separated using the anionic CD derivatives sulfobutyl ether-β-cyclodextrin (SBE-β-CD) 
and carboxymethyl-β-cyclodextrin (CM-β-CD) at pH 2.5. CM-β-CD resolved both 
analytes with good peak shape with resolution values of 7.88. However SBE-β-CD was 
discounted for this separation due to low enantioselectivity. The sensitivity of the 
methods was shown to be sufficient to meet current guidelines by being able to detect 
0.2% unwanted D-enantiomer in L-enantiomer samples. The simultaneous separation of 
all four analytes by CE using one chiral selector was not carried out. Instead two 
different selectors were favoured for each separation. This is another example of how 
there is no universal selector currently available for regulatory compliance testing. The 
choice of a suitable selector is entirely sample specific.    
Ha et al. also investigated the separation of L-DOPA and L-carbidopa by CZE using 
various neutral and charged cyclodextrins.18 It was discovered that neutral cyclodextrins 
(namely α-CD, β-CD, γ-CD, methyl-β-CD and hydroxypropyl-β-CD) had no effect on 
the chiral separation. Chiral resolution was successfully achieved using charged highly 
sulfated β-cyclodextrin and sulfated β-cyclodextrin as chiral selectors, in normal and 
reversed polarity mode. Ha et al. found that using normal polarity mode in this study led 
to excessive run times of over 50 mins and poor sensitivity. For this reason a reversed 
polarity method was developed and the run times were reduced to ~ 10 mins. It was 
possible to detect 0.1% of the D impurities in L-carbidopa and L-DOPA. The 
International Conference on Harmonization of Technical Requirements for Registration 
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of Pharmaceuticals for Human Use recommends an impurity level of 0.2 %, twice the 
level detectable in the method described above.18 
5.1.7 Experimental 
Analysis was performed on a Beckman P/ACE MDQ Method Development System 
(Fullerton, CA, USA) equipped with diode array detector (DAD) and controlled by 32 
Karat Software. The system performance was evaluated regularly using Beckman’s own 
performance test mix P/ACE MDQ Test Mix B with Run Buffer A. Separation was 
performed on an uncoated fused-silica capillary (50 cm total length, 37.5 cm effective 
length) at 12-25 kV. Capillary temperature was 20 oC and sample tray temperature 15 
oC. All solutions were prepared in HPLC grade water. A BGE at pH 6.8 was prepared 
by dissolving ammonium acetate in water to give a 0.002 M solution. Although 
ammonium acetate is not a true buffer, it has been shown to be useful as the BGE for 
CE experiments involving metallo-cyclodextrins as chiral selectors.19  Problems have 
been encountered when using true buffer solutions (such as NH3/NH4+) and metallo-
cyclodextrins due to competing coordination of the metal ion to components of the 
buffer system. A BGE at pH 2.5 was prepared by mixing 0.55 cm3 of 1 M sodium 
dihydrogen phosphate with 1.454 cm3 of 1 M ortho-phosphoric acid in water to give a 
0.02 M solution. Stock solutions of CDEn and CuSO4.5H2O of 0.1 M and DOPA and 
carbidopa of 0.001 M were prepared in HPLC grade water.  
The capillary was conditioned using the following parameters; 
Daily Rinse:  
• 0.1 mol dm-3 HCl (10 mins) 
• HPLC Grade H2O (5 mins) 
• 0.1 mol dm-3 NaOH (15 mins) 
• 0.02 mol dm-3BGE (15 mins) 
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Pre-run: 
• 0.1 mol dm-3 NaOH (3 mins) 
• BGE (5 mins) 
Values for the effective mobility µ (corrected for EOF) and resolution (Rs) were 
calculated using the following formulae,  
 
 
 
 
 
 
 
 
Equation 5.7 
 
 
 
Equation 5.8 
 
 
Equation 5.9 
 
where L = total capillary length (cm) and l = effective capillary length (cm) as 
determined by the manufacturer. ΔV = applied voltage (kV), t = migration time of 
analyte (mins.) and tEOF  =  migration time of neutral marker (mins.).  
 
 
 
Equation 5.10 
 
where t1 and t2 refer to the migration time of the first analyte to elute and second 
analyte to elute respectively and w1 and w2 are the peak widths of these analytes 
(mins.)   
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5.2 Results and Discussion 
5.2.1 Instrument Test  
A test mix separation was performed on each new capillary to verify the instrument was 
operating correctly. This was carried out using Beckman Test Mix B and Run Buffer A 
as sample and BGE respectively. The electropherogram was then compared to the 
example separation given in the CE user guide (Figure 5.13).  
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Figure 5.13 a) Electropherogram of Test Mix B. BGE was Run Buffer A and b) Electropherogram of Test Mix 
B supplied by Beckman P/ACE MDQ user guide 
a) 
b) 
Chapter 5  Capillary Electrophoresis 
 117  
The electropherograms compare very favourably and differ only in the migration times 
of the two peaks, due to the use of a shorter capillary in the system employed in this 
work (50 cm used by Beckman versus 37.5 cm effective length in this study). 
5.2.2 Separation of L-DOPA and L-Carbidopa 
To ensure there are no unwanted signals arising from the BGE an electropherogram of 
the BGE at pH 6.8 was recorded and is presented in Figure 5.14. From this it can be 
seen that injecting ammonium acetate as a sample results in a stable baseline with a 
stable current.  
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Figure 5.14 Electropherogram of system baseline using BGE at pH 6.8 0.02 M ammonium acetate as sample 
The velocity of migration of an analyte in capillary electrophoresis will depend upon the 
electroosmotic flow (EOF) which is measured using a neutral marker, in this case 
acetone. Normally 6-8 µL of acetone is added to each sample solution and its migration 
time compared to the migration times of the analyte peaks. It should be noted however, 
that when performing a separation using CuCD derivatives the EOF must be measured 
in a separate experiment, to avoid precipitates of non-soluble copper salts blocking the 
capillary. The electropherogram of acetone in BGE at pH 6.8 is given in Figure 5.15 
and shows a negative peak for acetone at 5.4 min. 
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Figure 5.15 Electropherogram of acetone (EOF Marker) in BGE at pH 6.8 
Any analyte with a net positive charge will migrate before acetone and an analyte with a 
net negative charge will migrate after acetone. The electropherograms of L-DOPA, L-
carbidopa and a mixture of the two in the presence of the neutral marker acetone were 
therefore recorded and are presented in Figure 5.16 a, b and c respectively. 
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Figure 5.16 Electropherograms of acetone and a) L-DOPA b) L-carbidopa and c) L-DOPA + L-carbidopa all at 
2.5x10-5 M with BGE at pH 6.8  
In the electropherogram shown in Figure 5.16a a signal can be seen co-migrating with 
the negative signal for acetone which is assigned to L-DOPA. Co-migration occurs at 
pH 6.8 as L-DOPA is in the zwitterionic form with a net charge of zero and therefore it 
a) 
b) 
c) 
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co-migrates with the neutral marker. L-Carbidopa shows a similar response (Figure 
5.16b). For the mixture of L-DOPA and L-carbidopa a signal can again be seen co-
migrating with the neutral marker indicating a neutral charge on the analytes but more 
importantly there is no evidence of separation (Figure 5.16c).    
The mobilities of both analytes were corrected by subtracting the mobility of the EOF 
(µEOF) from the analyte mobilities (µanalyte) to give their effective mobilities (µeffective) as 
described in the experimental section. Table 5.1 details the effective mobilities of L-
DOPA and L-carbidopa.  
Table 5.1 Calculated mobilities corrected for EOF 
Analyte Analyte Mobility  
(µanalyte) 
Mobility of EOF 
(µEOF) 
Effective Mobility
(µeffective) 
L-DOPA 0.482 0.501 -0.019 
L-Carbidopa 0.474 0.458 -0.016 
 
This result indicates that CE separation of the two analytes at this pH did not occur due 
to their similar effective mobilities and so a chiral selector is required. CuCDEn was 
therefore added to the same BGE to enhance the separation of the analytes. Work 
previously carried out by our group on chiral separations of tyrosine used concentration 
values of CDEn in the range of 1.2-48 mM.20 The concentration ratio of copper to 
CDEn was kept constant at 1.2:1 CDEn:Cu in order to limit the amount of free copper 
in the system and to ensure the formation of the binary CuCDEn complex.13,19,21,22  
Figure 5.17 below shows an electropherogram obtained using these conditions and a 
mixture of L-DOPA and L-carbidopa as analyte. 
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Figure 5.17 Electropherogram of L-DOPA + L-carbidopa both at 2.5x10-4 M with 1.8 mM CDEn 1.5 mM Cu 
added to BGE (pH 6.8, +20 kV) 
As can be seen from the above electropherogram no separation of the isomers has 
occurred. Various experimental conditions were changed such as CuCDEn 
concentration, ammonium acetate concentration and voltage. However successful 
separation of L-DOPA and L-carbidopa was not achieved using CuCDEn as a selector. 
pH can also influence separation. Ha et al. achieved successful separation of these 
analytes using various cyclodextrin derivatives at a pH of 2.5.18 Saraç et al. also used 
pH 2.5.17 However when using CuCDEn the pH range is limited to 6-8. Above this pH 
range insoluble copper hydroxides can form and below this range copper does not 
coordinate to CDEn. Therefore CuCDEn may be a poor choice of chiral selector due to 
the limited pH range. It was therefore decided to use CDEn alone as a chiral selector at 
pH 2.5. Figure 5.18 (a + b) shows the electropherograms obtained using CDEn at 
concentrations of 1 and 2 mM respectively.   
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Figure 5.18 Electropherogram of a) L-carbidopa + L-DOPA (both 5x10-4 M) with 1mM CDEn in BGE and b) 
L-carbidopa + L-DOPA (both 5x10-4 M) with 2mM CDEn in BGE (pH 2.5, +20kV)  
No separation of DOPA and carbidopa was achieved at the lower concentration. 
However baseline separation was achieved within ~ 16 mins. on increasing the CDEn 
concentration to 2 mM. Using Equation 5.11 the resolution was found to be Rs = 2.36. 
Ha et al. did not report Rs values for the separation of the isomers and Saraç et al. 
performed the separation of D,L-DOPA and D,L-carbidopa in separate experiments. 
Therefore direct comparison of resolution values is not possible and the only data that 
can be compared is the difference in migration time of the two analytes. In our work Δt 
is 0.66 mins. which compared well with Fanali et al. who show a value of 0.50 mins.     
a) 
b) 
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To determine the order of migration of the analytes the sample was spiked with excess 
L-DOPA and the electropherogram is presented in Figure 7.19.  
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Figure 5.19 Electropherogram of L-carbidopa (5x10-4 M) + L-DOPA (8.3x10-4 M) with 1mM CDEn (pH 2.5 
+25 kV) 
From the above electropherogram the order of migration was found with L-carbidopa 
migrating before L-DOPA.   
The same experiment was carried out using CE in reverse polarity mode. In this mode 
the positions of the anode and cathode are reversed with the anode placed at the detector 
end of the capillary. The capillary length between injection and detection is now shorter 
which can lead to reduced analysis time. Figure 5.20 compares the effect of normal and 
reversed polarity mode on effective capillary length. It should be noted that in reversed 
polarity mode the voltage used in order to decrease migration times must be decreased 
due to the shorter capillary length.  
  Detection 
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effective capillary length 
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Figure 5.20 Difference in effective capillary length in normal and reversed polarity modes 
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Figure 5.21 shows the electropherograms DOPA and carbidopa in reversed polarity 
mode.  
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Figure 5.21 Electropherogram of L-carbidopa (5x10-4 M) + L-DOPA (8.3x10-4 M) with  a) 2mM CDEn in BGE 
and b) 4 mM CDEn in BGE ( pH 2.5, -12kV) 
Comparing the electropherograms in Figure 5.21 shows that changing to reversed 
polarity mode reduced the migration times from ~ 16 minutes to 5 minutes. However 
the peak shape broadened but baseline separation still occurred (Figure 5.21a). It can 
also be seen that the order of migration changed so that DOPA migrated faster than 
carbidopa. Baseline separation was not achieved using 4 mM CDEn. Therefore the 
a) 
b) 
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optimum conditions were determined to be 2 mM CDEn in BGE at pH 2.5 in normal 
polarity mode and under these conditions the resolution was found to be 2.36.  
5.2.3 Separation of D- and L-DOPA 
In an attempt to separate the enantiomers of DOPA, the optimum parameters found for 
the successful separation of L-DOPA and L-carbidopa were applied. Figure 5.22 shows 
the electropherograms obtained when using CDEn as the chiral selector in the BGE at 
pH 2.5 and normal polarity mode. 
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Figure 5.22 Electropherogram of  D,L-DOPA (both 5x10-5 M) with a) 1 mM b) 2 mM and c) 4 mM CDEn in 
BGE at pH 2.5 (+20 kV) 
a) 
b) 
c) 
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From the electropherograms above it can be seen that there was no separation of D,L-
DOPA using CDEn in BGE at pH 2.5 and CE in forward polarity mode. Increasing the 
concentration of CDEn to facilitate the separation caused an increase in migration time 
(~ 25 minutes using 4 mM CDEn). Therefore electropherograms were recorded (Figure 
5.23) at higher concentrations of CDEn in reversed polarity mode in an attempt to 
achieve separation. 
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Figure 5.23 Electropherogram of  D,L-DOPA (both 5x10-5 M) using a) 6 mM b) 20 mM CDEn in BGE at pH 2.5 
(-12 kV) 
Figure 5.23a gives an electropherogram showing the reduced retention time of the 
analytes in reversed polarity mode. Partial separation was obtained using 20 mM CDEn 
a) 
b) 
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in the BGE at pH 2.5 and -12 kV (Figure 5.23b). Two peaks are evident in this 
electropherogram at 9.97 and 10.45 mins however they are not baseline separated. 
Further increases in the concentration of CDEn did not improve separation. 
The results obtained above agree with earlier suggestions that the amino-cyclodextrin 
derivatives may be guest specific as chiral selectors in CE. With this in mind sulfated-β-
cyclodextrin (SCD) was chosen as an alternative chiral selector to CDEn since anionic 
chiral selectors such as SCDs are useful for separating cationic analytes due to strong 
electrostatic interactions. In SCDs the hydroxyl groups are substituted by SO3- groups 
and the SCD used in this work had a degree of substitution of 7-11 substitutions per 
molecule.  
Figure 5.24 shows the electropherogram of D,L-DOPA separated using normal polarity 
mode and 0.2 % (w/v) SCD in the BGE (pH 2.5) using +25 kV. Two well defined peaks 
are visible in the electropherogram (L-DOPA migrating first) with a resolution value of 
3.62.  
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Figure 5.24 Electropherogram of  D,L-DOPA (excess L-DOPA) with 0.2 % (w/v) SCD in BGE (pH 2.5, +25 kV) 
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5.3 Conclusion of Capillary Electrophoresis Study 
The separation of L-carbidopa from L-DOPA, the components of many anti-Parkinson’s 
medications is a complex analytical problem due to the analytes having similar chemical 
structures. At pH 6.8 it was found that in CE their effective mobilities were very similar 
which did not allow for their separation when using ammonium acetate as a BGE. To 
enhance the separation CuCDEn was added to the BGE as a chiral selector. Despite 
changing the concentration of the chiral selector and BGE and changing the voltage, 
separation was not observed. 
Other workers have shown that at a more acidic pH of 2.5 the difference between the 
effective mobilities of carbidopa and DOPA is greater.16,17,18 However the binary 
complex CuCDEn does not form at this pH. Therefore CDEn alone was used as the 
selector. Separation of L-DOPA and L-carbidopa was achieved using 2 mM CDEn in the 
BGE at a pH of 2.5 and gave retention times of ~ 16 mins in normal polarity mode. The 
resolution was calculated to be 2.36 with DOPA migrating as the second peak. Lower 
migration times (~ 5 mins) were achieved by reversing the polarity.  
Chiral separation of D,L-DOPA was attempted and no separation was achieved in 
normal polarity mode. However there was some evidence of initial separation using 20 
mM CDEn in the BGE at pH 2.5 in reversed polarity mode, but no baseline separation 
was recorded. An alternative method was proposed using sulfated cyclodextrins 
(SCDs). Chiral resolution of D,L-DOPA was achieved in normal polarity mode using 0.2 
% (w/v) SCD in the BGE at pH 2.5 with a resolution of 3.62.   
In conclusion, the results obtained in this work suggest that the metallo-cyclodextrin 
derivatives are not versatile chiral selectors due to the fact that their use is limited by 
pH. These complexes are only stable within a pH range of 6.5-8. Amino-cyclodextrins 
are also not versatile selectors it is difficult to determine their exact mode of action but 
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since they are neutral molecules it is possible that they give a narrow separation 
window. Unlike the anionic sulfated derivatives they will not have strong interactions 
with cationic analytes. Therefore there will be little difference in the mobility of free 
and complexed analytes. Cucinotta et al. has suggested that the separation mechanism 
of charged cyclodextrin derivatives relies on the differences in the velocity of migration 
between the analyte and the analyte-CD complex. 23 Wren and Rowe suggest that for 
separation of enantiomers it is necessary to maximise the difference in the stability 
constants of the diastereomeric complexes with CD.24 Therefore electrostatic 
interactions between charged CDs and charged analytes may not be the only factor 
influencing separation.    
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In this work copper(II) complexes of aminoalkane derivatives of β-cyclodextrin (CDEn, 
CDPn and CDBn) were investigated to determine if they provide a more versatile 
solution than sulfated derivatives for  the direct separation of enantiomers and analytes 
with similar chemical structures (DOPA, benserazide and carbidopa) using capillary 
electrophoresis. Tyrosine was used as a model compound.  
Binary complexes of the amino-CD derivatives with copper(II) were formed in solution 
and were analysed using electronic absorption spectroscopy. Significant shifts in the 
position of λmax for the d-d transition of copper(II) showed the successful coordination 
of Cu(II) to the amino group of the CDs. The results suggested that CDEn and CDPn 
behave as bidentate ligands and coordinate to the metal ion through the two nitrogen 
atoms of the diaminoalkane moiety. The shift in λmax for CDBn was less pronounced 
indicating it acts as a monodentate ligand as a result of the longer aminoalkane chain. 
The complexation of these binary complexes with D,L-tyrosine, D,L-DOPA and L-
carbidopa resulted in the formation of ternary complexes. Evidence of the formation of 
these complexes was demonstrated by further hypsochromic shifts in λmax for the d-d 
transition of copper(II). It was also found that benserazide did not form a stable 
complex with any of the binary complexes. 
To assess the enantioselective properties of the CuCDAm species both the binary and 
ternary complexes of tyrosine and DOPA were studied using circular dichroism 
spectroscopy. The study allowed the examination of the degree of inclusion of the guest 
moieties within the cyclodextrin cavity. It was proposed that due to structural 
restrictions imposed by both the CD cavity and the presence of the metal centre caused 
two configurations to form for the L and D ternary complexes and that these take the 
form of diastereoisomers one with the aromatic side-chain orientated away from the CD 
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cavity and one towards or in the cavity. The results suggested that [CuCDEn]2+ was the 
most effective chiral selector of those studied for both guests.  
The stoichiometry of all the complexes formed was studied using the Job’s method of 
continuous variation. Table 6.1 summarises the results obtained. 
 
Table 6.1 Results of the continuous variation study showing complex stoichiometries 
Metal Ligand Stoichiometry 
Cu(II) CDEn 1:1 
Cu(II) D-tyrosine 1:1 and 1:2 
Cu(II) L-tyrosine 1:1 and 1:2 
Cu(II) D-DOPA 1:1 and 2:1 
Cu(II) L-DOPA 1:1 and 2:1 
Cu(II) L-carbidopa 1:1 
 
Host Guest Stoichiometry 
CuCDEn D-tyrosine 1:1 
CuCDEn L-tyrosine 1:1 
CuCDEn D-DOPA 2:1 
CuCDEn L-DOPA 2:1 
CuCDEn L-carbidopa 1:1 and 2:1 
 
Combining the results of the electronic absorption, circular dichroism and stoichiometry 
studies allows us to suggest the following ternary complex structures in Figure 6.1-6.3.  
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Figure 6.1 Proposed structures of the ternary complexes of D,L-tyrosine with [CuCDEn]2+ at pH 6.8 
Support for these structures can be obtained from electronic spectroscopy which 
indicated coordination to the metal centre via the nitrogen of the amine group and 
oxygen of the carboxyl group of tyrosine. Circular dichroism also indicated a difference 
in inclusion between the two enantiomers, with D-tyrosine showing deeper inclusion 
into the CD cavity. The stoichiometric study showed 1:1 complexation for 
CuCDEn:tyrosine. Further support for the proposed structure can be obtained from 
Maccarrone et al. who proposed similar structures for the diastereoisomeric ternary 
complexes of tryptophan and CuCDEn.1     
For DOPA a hypsochromic shift in the absorption spectrum for the ternary complex 
with CuCDEn versus the binary complex indicated further coordination of DOPA to the 
metal centre. Again c.d. spectroscopy shows differential inclusion between the two 
enantiomers with results indicating D-DOPA is included more fully than L-DOPA. The 
Job’s plot indicated 2:1 complexation for CuCDEn:DOPA. These results led to the 
following proposed structures (Figure 6.2).   
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Figure 6.2 Proposed structures of the ternary complexes of D,L-DOPA with [CuCDEn]2+ at pH 6.8 
Electronic spectroscopy also suggested coordination of L-carbidopa to CuCDEn via the 
carboxyl and amino groups. The stoichiometric study suggested the existence of both 
1:1 and 2:1 CuCDEn:L-carbidopa ternary complexes in solution. Due to the lack of a 
commercially available sample of D-carbidopa a circular dichroic experiment could not 
be carried out and therefore it is not possible to compare inclusion of the enantiomers in 
the CD cavity. However since the structures of DOPA and carbidopa are similar it is 
possible that the ternary complexes also have similar structures and therefore proposed 
structures for the carbidopa complexes are shown in Figure 6.3. 
 
Chapter 6 Conclusion 
 138  
HN
NH2
OH
HO
O-
HN CH3
O
N
H3+
Cu2+ HN
NH2
OH
HO
O
HN CH3
O
N
H3+
Cu2+
NHH2N
Cu2+
[L-carbidopa(CuCDEn)]2+ [L-carbidopa(CuCDEn)2]4+  
Figure 6.3 Proposed structures of the ternary complexes of L-carbidopa with [CuCDEn]2+ at pH 6.8 
The circular dichroism study suggested that CuCDEn may be the most effective chiral 
selector of those studied for the chiral separation for DOPA. In the capillary 
electrophoresis study CuCDEn was added to the BGE at pH 6.8 in an effort to resolve 
the enantiomers of DOPA and perform the separation of L-DOPA from L-carbidopa. 
The separation of L-carbidopa from L-DOPA is a complex analytical problem due to the 
analytes having similar chemical structures. At pH 6.8 it was found that their effective 
mobilities were very similar which did not allow for their separation when using 
ammonium acetate alone as a BGE. To enhance the separation CuCDEn was added to 
the BGE. Changes to various experimental conditions were explored such as CuCDEn 
concentration, ammonium acetate concentration and voltage. However successful 
separation of L-DOPA and L-carbidopa was not achieved.  
Other workers have shown that at a more acidic pH of 2.5 the difference between the 
effective mobilities of carbidopa and DOPA is greater.2,3,4 However the binary complex 
CuCDEn does not form at this pH. Therefore CDEn alone was used as the selector in 
the BGE at pH 2.5. Separation of L-DOPA and L-carbidopa was achieved using 2 mM 
CDEn and gave retention times of ~ 16 mins. The resolution was calculated to be 2.36 
with DOPA migrating as the second peak. Lower migration times (~ 5 mins) were 
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achieved by reversing the polarity. To the best of the author’s knowledge this represents 
the first time DOPA and carbidopa have been separated using CDEn.  
Chiral separation of D,L-DOPA was attempted and no separation was achieved in 
normal polarity mode. However there was some evidence of initial separation using 20 
mM CDEn in the BGE at pH 2.5 in reversed polarity mode, but no baseline separation 
was recorded. An alternative method was proposed using sulfated cyclodextrins (SCDs) 
as a chiral selector. Chiral resolution of D,L-DOPA was achieved using 0.2 % (w/v) 
SCD in the BGE at pH 2.5 with a resolution of 3.62 in normal polarity mode.   
In conclusion, the results obtained in this work suggest that amino-cyclodextrin 
derivatives are guest selective for chiral separations in capillary electrophoresis and do 
not represent a universal method for separations required for regulatory compliance. 
Since separations were obtained using the anionic sulfated derivatives it is suggested 
that host molecules with a permanent charge are more useful and therefore inclusion is 
not the only factor needed for separation to be successful. Since the sulfated group is a 
coordinating ligand it would be interesting in future to investigate if metallo complexes 
of SCDs can be formed and to study their enantioselective ability.  
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7. Synthesis and Characterisation 
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7.1 Introduction 
The following section details the materials and methods used in the synthesis and 
characterisation of 6-O-monotosyl-6-deoxy-β-cyclodextrin (CDTs), 6-deoxy-6-[1-(2-
amino)ethylamino]-β-cyclodextrin (CDEn), 6-deoxy-6-[1-(3-amino)propylamino]-β-
cyclodextrin (CDPn) and 6-deoxy-6-[1-(4-amino)butylamino]-β-cyclodextrin (CDBn).  
Amino derivatives of CDs can be prepared by an indirect approach.  A widely used 
intermediate is mono-6-deoxy-6-tosyl-β-cyclodextrin (CDTs).  A common method for 
preparation of CDTs involves reaction of β-CD with excess p-toluenesulphonyl 
chloride, with recrystallisation from water.1 Due to the importance of these sulphonates 
acting as intermediates for the further synthesis of other modified CDs, there exist many 
other methods of preparation.2, 3, 4, 5  For instance CDTs can be prepared by the reaction 
of β-CD with p-toluenesulphonyl chloride in pyridine.1  This route has the disadvantage 
that the product is obtained in poor yield and must be separated from multitosylated by-
products by chromatography along with the inherent difficulties of using pyridine as a 
solvent.  The synthesis used in this study is a slightly modified version of an aqueous-
based method reported by Brady et al.4  
Monoamine derivatives of CDs have been prepared by the treatment of the 
corresponding tosylate with ammonia.1 Analogous reactions of primary and secondary 
amines have also been reported as a method for attaching amino groups at the C6 
position of a CD.6  These materials can then be exploited for further modification, since 
the amino groups are substantially more nucleophilic than the CD hydroxyl groups. 
Matsui et al. published a synthesis route for 6-deoxy-6-[1-(2-amino)ethylamino]-β-
cyclodextrin (CDEn) in 1976.9  A modified version of Matsui’s synthesis was also 
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reported by Singh et al.7  The diaminoalkane derivatives CDEn, CDPn and CDPn 
prepared here follow a modified synthesis of the route proposed by Singh et al. 
7.2 Experimental 
All materials were purchased from commercial sources and were used without further 
purification. β-Cyclodextrin was supplied kindly by Wacker Chemie UK. Percentage 
yields are given based on the hydrated material and melting points as a decomposition 
range. Decomposition ranges were recorded using an Electrothermal 9100 melting point 
apparatus. It should be noted that the decomposition ranges given here (m.p. (dec.)) are 
the temperature at which the sample started to change colour. 
1H and 13C NMR spectra for β-CD and its derivatives were measured at 100 and 400 
MHz respectively, using a Bruker Avance III 400 NMR spectrometer. Spectra were 
recorded at room temperature using DMSO (for β-CD and tosylated derivatives) and 
D2O (for amino derivatives) as solvents. Spectra were referenced to the solvent peaks.  
FTIR spectra were recorded at room temperature using a Perkin Elmer Spectrum GX 
FTIR Spectrometer. Spectra were obtained of solid samples as KBr disks.  The spectra 
were measured over a range of 4000-370 cm-1 with a resolution of 4 cm-1, an interval of 
0.5 cm-1 and an accumulation of 16. 
Raman spectra were recorded using a LabRAM HR System Raman Spectrometer. The 
Raman spectrometer is controlled using the software package Labspec 5. All Raman 
spectra of solid samples were collected at room temperature using the following 
parameters: Time: 30 s, Accumulation: 10, Grating: 1800 lines/mm, Slit: 900 μm, 
Laser: 785 nm, Objective: 10×, Filter: 100 %, Hole: 900 μm. After alignment of optics, 
the system was calibrated using silicon as a calibrant (520 nm).  A spectral window of 
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200-4000 cm-1 was used.  The laser beam was focused on the solid sample and the 
scattered radiation efficiently gathered by the objective of the microscope. 
7.3 Results 
All of the results obtained compare favourably with work previously carried out by this 
group and other workers.1,4,7,8,9,10 
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Synthesis of 6-O-monotosyl-6-Deoxy-β-cyclodextrin (CDTs) 
OH
+ H3C S
O
O
Cl
0-4 oC
0.4 M NaOH
OTs
+ HCl
β-CD p-toluenesulphonyl chloride β-CDTs  
Scheme 7.1 Synthesis of 6-O-monotosyl-6-deoxy-β-cyclodextrin (CDTs) 
β-cyclodextrin hydrate (10.01 g, 7.61 mmol) was dissolved in NaOH (100 cm3 of 0.4 
mol dm-3). The solution was cooled in ice and p-toluenesulphonyl chloride (3 g, 
15.79 mmol) was added. The mixture was stirred for 3 hours at 0 – 4 oC.  The 
mixture was then filtered and the pH of the filtrate adjusted to 6.5 using HCl (1 mol 
dm-3, 20 cm3) and a precipitate formed. The filtrate was cooled at 4 oC for 24 hours.  
The product was removed by filtration, washed with acetone and recrystallised from 
water several times.  The solid was recovered by filtration, washed with acetone and 
allowed to dry at 60 °C for 4 hours.  It should be noted that rapid cooling to 60 °C of 
the mixture was employed during the recrystallisation to avoid significant 
hydrolysis.4 
Yield: 4.89 g, 45% (based on hydrated material) Literature Value: 20-30 %10 
m.p: 163 oC (dec.) Literature Value: 161-162 oC10 
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 1H NMR (DMSO) δ (ppm) 7.74 (H8) 7.42 (H9) 5.73 (OH2, OH3) 4.83 (H1) 
4.46 (OH6) 4.32 (H6b) 3.66 (H6) 3.60 (H3) 3.51 (H5) 3.32 (H4) 3.21 (H2) 2.43 
(H11) 
 13C NMR (DMSO) δ (ppm) 144.88 (C10) 132.64 (C7) 129.93 (C9) 127.61 
(C8) 102.25 (C1’) 101.94 (C1) 101.29 (C1’’) 81.66 (C4’) 81.50 (C4’’) 81.15 (C4) 
73.08 (C3) 72.70 (C2’ or C3’) 72.43 (C2) 72.07 (C5) 69.76 (C6’) 68.95 (C5’) 59.95 
(C6) 59.91 (C6’’) 21.24 (C11). 
 FTIR (cm-1) 1647 (complexed water), 1364 (asymmetric SO2-O stretch), 1159 
(symmetric SO2-O stretch), 837 and 814 (para-disubstituted benzene ring )* 
 Raman (cm-1) 3061 (aromatic C-H stretch of alkyl benzene), 1597 (ring stretch 
of benzene derivatives), 1208 and 1178 (symmetric SO2 stretch), 796 (ring vibration 
of para-disubstituted benzene), 669 (benzene ring in-plane deformations), 634 
(benzene ring in-plane deformations)*  
*New bands relative to β-CD 
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Synthesis of 6-deoxy-6-[1-(2-amino)ethylamino]-β-cyclodextrin (CDEn) 
 
OTs
β-CDTs
+ NH2(CH2)2NH2
70oC
NH
NH2
β−CDEn
+   TsOH
 
Scheme 7.2 Synthesis of 6-deoxy-6-[1-(2-amino)ethylamino]-β-cyclodextrin (CDEn) 
6-O-monotosyl-6-deoxy-β-cyclodextrin (β-CDTs) (19.28 g, 13.45 mmol) was 
dissolved in 1,2 diaminoethane (70 cm3, 1.05 mol) and refluxed under nitrogen for 24 
hours at 70 oC.  The mixture was then concentrated under vacuum and gave a pale 
yellow viscous oil.  The oil was then dissolved in a minimum volume of water: 
methanol (3:1) mixture.  The solution was then slowly added to cold acetone and a 
precipitate formed.  The precipitate was recovered by filtration, washed with acetone 
and dried in air.  The product was dissolved in a minimum volume of water (60 °C).  
A minimum volume of acetone was added to just initiate crystallization and the 
mixture was cooled to 4 °C.  The product was recovered by filtration, washed with 
acetone and dried at 60 °C for 4 hours. To achieve a pure product the recrystallization 
step was repeated 3-4 times.  
Yield: 14 g, 76.5 % (based on hydrated material) Literature Value: 37-60 %10 
m.p: 250 oC (dec.) Literature Value: 268-271 oC10 
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  1H NMR (D2O) δ (ppm): 5.09 (H1β), 3.94 (H3), 3.84 (H6a,b), 3.83 (H5), 3.62 
(H2), 3.57 (H4), 3.45 (H4’), 3.04 (H6’α), 2.81 (H6’β, H8), 2.71 (H7) 
  13C NMR (D2O) δ (ppm): 101.77 (C1), 101.49 (C1’), 83.42 (C4’), 81.03 (C4) 
80.86 (C4’’), 72.99 (C3), 72.93 (C2’/C3’), 71.95 (C2), 71.70 (C5), 70.33 (C5’), 
60.15 (C6), 49.41 (C9), 49.08 (C6’), 39.33 (C8). 
  FTIR (cm-1) 1622 (complexed water), 1586 (N-H bending vibrations), 1492 
(C-H2 scissoring mode of aminoalkane group), 818 (N-H wag)* 
 Raman (cm-1) 3520 (N-H stretch)* 
 
*These are new bands relative to β-CD 
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Synthesis of 6-Deoxy-6-[1-(3-amino)propylamino]-β-cyclodextrin (CDPn) 
 
OTs
β-CDTs
+ NH2(CH2)3NH2
70oC
NH
β−CDPn
+   TsOH
NH2
 
Scheme 7.3 Synthesis of 6-deoxy-6-[1-(3-amino)propylamino]-β-cyclodextrin (CDPn) 
6-O-monotosyl-6-deoxy-β-cyclodextrin (β-CDTs) (3.97 g, 2.77 mmol) was dissolved 
in 1,3 diaminoethane (18 cm3, 0.216 mol) and refluxed under nitrogen for 24 hours at 
70 oC.  The mixture was then concentrated under vacuum and gave a pale yellow 
viscous oil.  The oil was then dissolved in a minimum volume of water: methanol 
(3:1) mixture.  The solution was then slowly added to cold acetone and a precipitate 
formed.  The precipitate was recovered by filtration, washed with acetone and dried 
in air.  The product was dissolved in a minimum volume of water (60 °C).  A 
minimum volume of acetone was added to just initiate crystallization and the mixture 
was cooled to 4 °C.  The product was recovered by filtration, washed with acetone 
and dried at 60 °C for 4 hours. The recystallization step was repeated 3-4 times to 
achieve a pure product.  
Yield: 2.54 g, 66 % (based on hydrated material) Literature Value: 93 %10 
m.p: 260 oC (dec.) Literature Value: 268-271 oC10 
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  1H NMR (D2O) δ (ppm): 5.04 (H1β), 3.94 (H3), 3.84 (H6a,b), 3.81 (H5), 3.61 
(H2), 3.55 (H4), 3.4 (H4’), 3.01 (H6’b), 2.80 (H6’a, H9), 2.60 (H7), 1.71 (H8) 
  13C NMR (D2O) δ (ppm): 101.7 (C1), 101.4 (C1’), 83.5 (C4’), 81.0 (C4) 80.7 
(C4’’), 72.9 (C3), 72.9 (C2’/C3’), 71.9 (C2), 71.7 (C5), 70.2 (C5’), 60.1 (C6), 49.3 
(C6’), 46.2 (C7), 38.1 (C9), 29.0 (C8) 
  FTIR (cm-1) 1634 (complexed water), 1572 (N-H bending vibration), 1485, 
1472 (C-H2 scissoring mode of aminoalkane group), 818 (N-H wag)* 
  Raman (cm-1) 3533 (N-H stretch)* 
*These are new bands relative to β-CD 
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Synthesis of 6-Deoxy-6-[1-(4-amino)butylamino]-β-cyclodextrin (CDBn)  
 
OTs
β-CDTs
+ NH2(CH2)4NH2
70oC
NH
β−CDBn
+   TsOH
NH2
 
Scheme 7.4 Synthesis of 6-deoxy-6-[1-(4-amino)butylamino]-β-cyclodextrin (CDBn) 
6-O-monotosyl-6-deoxy-β-cyclodextrin (β-CDTs) (4.00 g, 2.79 mmol) was dissolved 
in 1,4 diaminobutane (22 cm3, 0.248 mol) and refluxed under nitrogen for 24 hours at 
70 oC.  The mixture was then concentrated under vacuum and gave a pale yellow 
viscous oil.  The oil was then dissolved in a minimum volume of water: methanol 
(3:1) mixture.  The solution was then slowly added to cold acetone and a precipitate 
formed.  The precipitate was recovered by filtration, washed with acetone and dried 
in air.  The product was dissolved in a minimum volume of water (60 °C).  A 
minimum volume of acetone was added to just initiate crystallization and the mixture 
was cooled to 4 °C.  The product was recovered by filtration, washed with acetone 
and dried at 60 °C for 4 hours. The recystallization step was repeated 3-4 times to 
achieve a pure product. 
Yield: 2.8 g, 72 % (based on hydrated material) Literature Value: 71 %10 
m.p: 260 oC (dec.) Literature Value: 260 oC10  
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1H NMR (D2O) δ (ppm): 5.04 (H1β), 3.95 (H3), 3.92 (H6a,b), 3.84 (H5), 3.60 
(H2), 3.55 (H4), 3.40 (H4’), 3.02 (H6’a), 2.81 (H6’b, H10), 2.58 (H7), 1.54 (H8,H9)  
  13C NMR (D2O) δ (ppm): 101.75 (C1), 101.40 (C1’) 83.43 (C4’), 81.01 (C4), 
80.74(C4’’) 72.98 (C3), 72.98 (C2’/C3’), 71.93 (C2), 71.93 (C5), 71.70 (C5’), 60.16 
(C6), 49.29 (C7), 48.36 (C6’), 39.67 (C10), 26.62 (C9). 25.67 (C8) 
  FTIR (cm-1) 1653 (complexed water), 1634 (N-H bending vibration), 1489, 
1472 (C-H2 scissoring mode of aminoalkane group), 816 (N-H wag)* 
  Raman (cm-1) 3534 (N-H stretch)* 
*These are new bands relative to β-CD 
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8.1 Electronic Spectroscopy 
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Figure 8.1 Electronic spectra of 1) CDEn, 2) CDPn and 3) CDBn 0.002 M in 0.01 M phosphate buffer pH 7.2 
(10 mm cell)  
Wavelength (nm)
200 300 400 500 600 700 800
A
bs
or
ba
nc
e 
(a
.u
.)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
223
275
 
 
3 
1 
Appendix  Reference Spectra 
 161 
Wavelength (nm)
200 300 400 500 600 700 800
A
bs
or
ba
nc
e 
(a
.u
.)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
275
223
 
Figure 8.2 Electronic spectra of 1) L-tyrosine and 2) D-tyrosine 0.001 M in 0.01 M phosphate buffer pH 7.2 
(1mm cell) 
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Figure 8.3 Electronic spectra of 1) L-DOPA and 2) D-DOPA 0.002 M in 0.01 M phosphate buffer pH 7.2 (1mm 
cell) 
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Figure 8.4 Electronic spectrum of L-carbidopa 0.002 M in 0.01 M phosphate buffer pH 7.2 (1mm cell) 
Table 8.1 λmax and ε values for the CD derivatives, guests and binary complexes at pH 7.2 
Host λmax 
(nm) 
ε 
(mol-1 dm3 cm-1) 
   
CDEn 244 27 
308 4 
237 28 
CDPn 
222 47 
302 3 CDBn 
240 33 
   
Ligand/Guest  
2 
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275 1477 L-Tyrosine 
223 8966 
275 1586 D-Tyrosine 
223 9548 
280 3240 L-DOPA 
218 7556 
280 3171 D-DOPA 
218 7435 
   
Binary Complex  
  
671 69 [Cu(CDEn)]2+ 
254 4557 
716 79 
250 3143 
[Cu(CDPn)]2+ 
230 2958 
731 70 [Cu(CDBn)]2+ 
242 2179 
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8.2 Stoichiometry of Complexes 
 Table 8.2 Results of spectral titration of Cu(II) with CDEn 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
CDEn 
(µl) 
Total 
(µl) 
Absorbance 
(650 nm) 
[Cu]/ 
[Cu+CDEn] 
1 0 2000 2000 0.0066 0.0 
2 100 1900 2000 0.0077 0.05 
3 200 1800 2000 0.0190 0.10 
4 300 1700 2000 0.0248 0.15 
5 400 1600 2000 0.0280 0.20 
6 500 1500 2000 0.0325 0.25 
7 600 1400 2000 0.0315 0.30 
8 700 1300 2000 0.0469 0.35 
9 800 1200 2000 0.0499 0.40 
10 900 1100 2000 0.0505 0.45 
11 1000 1000 2000 0.0526 0.50 
12 1100 900 2000 0.0488 0.55 
13 1200 800 2000 0.0462 0.60 
14 1300 700 2000 0.0394 0.65 
15 1400 600 2000 0.0383 0.70 
16 1500 500 2000 0.0336 0.75 
17 1600 400 2000 0.0289 0.80 
18 1700 300 2000 0.0231 0.85 
19 1800 200 2000 0.0183 0.90 
20 1900 100 2000 0.0120 0.95 
21 2000 0 2000 0.0080 1.0 
 
Table 8.3 Results of spectral titration of Cu(II) with D-Tyr 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
D-Tyr 
(µl) 
Total 
(µl) 
Absorbance 
(250 nm) 
[Cu]/ 
[Cu +D-Tyr] 
1 1500 0 1500 0.0000 0 
2 1200 300 1500 0.0328 0.2 
3 1050 450 1500 0.0487 0.3 
4 900 600 1500 0.0612 0.4 
5 750 750 1500 0.0730 0.5 
6 600 900 1500 0.0851 0.6 
7 450 1050 1500 0.0828 0.7 
8 300 1200 1500 0.0687 0.8 
9 0 1500 1500 0.0000 1 
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Table 8.4 Results of spectral titration of Cu(II) with L-Tyr 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
D-Tyr 
(µl) 
Total 
(µl) 
Absorbance 
(250 nm) 
[Cu]/ 
[Cu +D-Tyr] 
1 1500 0 1500 0.0000 0 
2 1200 300 1500 0.0245 0.2 
3 1050 450 1500 0.0362 0.3 
4 900 600 1500 0.0405 0.4 
5 750 750 1500 0.0552 0.5 
6 600 900 1500 0.0654 0.6 
7 450 1050 1500 0.0730 0.7 
8 300 1200 1500 0.0545 0.8 
9 0 1500 1500 0.0000 1 
 
Table 8.5 Results of spectral titration of CuCDEn with D-Tyr 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
D-Tyr 
(µl) 
Total 
(µl) 
Absorbance 
(250 nm) 
[Cu]/ 
[Cu +D-Tyr] 
1 1500 0 1500 0.0000 1 
2 1350 150 1500 0.0205 0.9 
3 1200 300 1500 0.0323 0.8 
4 1050 450 1500 0.0657 0.7 
5 900 600 1500 0.0692 0.6 
6 750 750 1500 0.0656 0.5 
7 600 900 1500 0.0559 0.4 
8 450 1050 1500 0.0379 0.3 
9 300 1200 1500 0.0204 0.2 
10 150 1350 1500 0.0000 0.1 
11 0 1500 1500 0.0000 0 
 
Table 8.6 Results of spectral titration of CuCDEn with L-Tyr 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
L-Tyr 
(µl) 
Total 
(µl) 
Absorbance 
(250 nm) 
[Cu]/ 
[Cu +L-Tyr] 
1 1500 0 1500 0.0000 1 
2 1200 300 1500 0.0149 0.8 
3 900 600 1500 0.0624 0.6 
4 750 750 1500 0.0647 0.5 
5 600 900 1500 0.0696 0.4 
6 450 1050 1500 0.0550 0.3 
7 300 1200 1500 0.0347 0.2 
8 0 1500 1500 0.0000 0 
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Table 8.7 Results of spectral titration of Cu(II) with D-DOPA 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
D-DOPA 
(µl) 
Total 
(µl) 
Absorbance 
(709 nm) 
[Cu]/ 
[Cu +DOPA] 
1 0 2000 2000 6.5700e-4 0 
2 100 1900 2000 6.4142e-3 0.05 
3 200 1800 2000 0.0103 0.1 
4 300 1700 2000 0.0209 0.15 
5 400 1600 2000 0.0158 0.2 
6 500 1500 2000 0.0203 0.25 
7 600 1400 2000 0.0212 0.3 
8 700 1300 2000 0.0299 0.35 
9 800 1200 2000 0.0302 0.4 
10 900 1100 2000 0.0315 0.45 
11 1000 1000 2000 0.0306 0.5 
12 1100 900 2000 0.0319 0.55 
13 1200 800 2000 0.0306 0.6 
14 1300 700 2000 0.0297 0.65 
15 1400 600 2000 0.0276 0.7 
16 1500 500 2000 0.0252 0.75 
17 1600 400 2000 0.0208 0.8 
18 1700 300 2000 0.0177 0.85 
19 1800 200 2000 0.0112 0.9 
20 1900 100 2000 6.7488e-3 0.95 
21 2000 0 2000 0.0000 1 
 
Table 8.8 Results of spectral titration of Cu(II) with L-DOPA 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
L-DOPA 
(µl) 
Total 
(µl) 
Absorbance 
(709 nm) 
[Cu]/ 
[CU+DOPA] 
1 0 2000 2000 1.9020e-3 0 
2 100 1900 2000 7.9010e-3 0.05 
3 200 1800 2000 9.1300e-3 0.1 
4 300 1700 2000 0.0135 0.15 
5 400 1600 2000 0.0165 0.2 
6 500 1500 2000 0.0159 0.25 
7 600 1400 2000 0.0256 0.3 
8 700 1300 2000 0.0313 0.35 
9 800 1200 2000 0.0365 0.4 
10 900 1100 2000 0.0380 0.45 
11 1000 1000 2000 0.0401 0.5 
12 1100 900 2000 0.0408 0.55 
13 1200 800 2000 0.0394 0.6 
14 1300 700 2000 0.0392 0.65 
15 1400 600 2000 0.0402 0.7 
16 1500 500 2000 0.0316 0.75 
17 1600 400 2000 0.0300 0.8 
18 1700 300 2000 0.0148 0.85 
19 1800 200 2000 0.0121 0.9 
20 1900 100 2000 5.3850e-3 0.95 
21 2000 0 2000 0.0000 1 
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Table 8.9 Results of spectral titration of CuCDEn with D-DOPA 
Sample 0.002 M 
D-DOPA 
(µl) 
0.002 M 
CuCDEn 
(µl) 
Total 
(µl) 
Absorbance 
(650 nm) 
[CuCDEn]/ 
[CuCDEn+D-
DOPA] 
1 0 2000 2000 0.0000 1 
2 100 1900 2000 0.0213 0.95 
3 200 1800 2000 0.0387 0.9 
4 300 1700 2000 0.0524 0.85 
5 400 1600 2000 0.0771 0.8 
6 500 1500 2000 0.0814 0.75 
7 600 1400 2000 0.0903 0.7 
8 700 1300 2000 0.0893 0.65 
9 800 1200 2000 0.0848 0.6 
10 900 1100 2000 0.0880 0.55 
11 1000 1000 2000 0.0509 0.5 
12 1100 900 2000 0.0406 0.45 
13 1200 800 2000 0.0430 0.4 
14 1300 700 2000 0.0308 0.35 
15 1400 600 2000 0.0266 0.3 
16 1500 500 2000 0.0195 0.25 
17 1600 400 2000 0.0135 0.2 
18 1700 300 2000 8.1920e-3 0.15 
19 1800 200 2000 5.8297e-3 0.1 
20 1900 100 2000 3.4714e-3 0.05 
21 2000 0 2000 0.0000 0 
 
Table 8.10 Results of spectral titration of CuCDEn with L-DOPA 
Sample D-DOPA 
(µl) 
CuCDEn 
(µl) 
Total 
(µl) 
Absorbance 
(650 nm) 
[CuCDEn]/ 
[L-DOPA] 
1 0 2000 2000 0.0000 1 
2 100 1900 2000 0.0182 0.95 
3 200 1800 2000 0.0336 0.9 
4 300 1700 2000 0.0454 0.85 
5 400 1600 2000 0.0700 0.8 
6 500 1500 2000 0.0683 0.75 
7 600 1400 2000 0.0651 0.7 
8 700 1300 2000 0.0666 0.65 
9 800 1200 2000 0.0586 0.6 
10 900 1100 2000 0.0563 0.55 
11 1000 1000 2000 0.0420 0.5 
12 1100 900 2000 0.0365 0.45 
13 1200 800 2000 0.0301 0.4 
14 1300 700 2000 0.0289 0.35 
15 1400 600 2000 0.0160 0.3 
16 1500 500 2000 0.0225 0.25 
17 1600 400 2000 9.1800e-3 0.2 
18 1700 300 2000 0.0152 0.15 
19 1800 200 2000 3.8900e-3 0.1 
20 1900 100 2000 7.5950e-3 0.05 
21 2000 0 2000 0.0000 0 
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Table 8.11 Results of spectral titration of Cu with L-carbidopa 
Sample 0.002 M 
Cu 
(µl) 
0.002 M 
carbidopa 
(µl) 
Total 
(µl) 
Absorbance 
(500 nm) 
[Cu]/ 
[Cu+carbidopa] 
1 2000 0 2000 0.0000 1 
2 1900 100 2000 0.1266 0.95 
3 1800 200 2000 0.1704 0.90 
4 1700 300 2000 0.2310 0.85 
5 1600 400 2000 0.2492 0.80 
6 1500 500 2000 0.2610 0.75 
7 1400 600 2000 0.2662 0.70 
8 1300 700 2000 0.2706 0.65 
9 1200 800 2000 0.2864 0.60 
10 1100 900 2000 0.2824 0.55 
11 1000 1000 2000 - 0.50 
12 900 1100 2000 0.2638 0.45 
13 800 1200 2000 0.3079 0.40 
14 700 1300 2000 0.2769 0.35 
15 600 1400 2000 0.2241 0.30 
16 500 1500 2000 0.1769 0.25 
17 400 1600 2000 0.1468 0.20 
18 300 1700 2000 0.1437 0.15 
19 200 1800 2000 0.1035 0.10 
20 100 1900 2000 0.0497 0.05 
21 0 2000 2000 0.0000 0 
 
Table 8.12 Results of spectral titration of CuCDEn with L-carbidopa 
Sample L-
carbidopa 
(µl) 
CuCDEn 
(µl) 
Total 
(µl) 
Absorbance 
(450 nm) 
[CuCDEn]/ 
[L-carbidopa] 
1 0 2000 2000 0.00E+00 1 
2 100 1900 2000 2.59E-02 0.95 
3 200 1800 2000 4.42E-02 0.9 
4 300 1700 2000 4.40E-02 0.85 
5 400 1600 2000 5.05E-02 0.8 
6 500 1500 2000 6.10E-02 0.75 
7 600 1400 2000 5.43E-02 0.7 
8 700 1300 2000 5.53E-02 0.65 
9 800 1200 2000 5.40E-02 0.6 
10 900 1100 2000 5.05E-02 0.55 
11 1000 1000 2000 4.82E-02 0.5 
12 1100 900 2000 4.30E-02 0.45 
13 1200 800 2000 4.22E-02 0.4 
14 1300 700 2000 4.26E-02 0.35 
15 1400 600 2000 3.63E-02 0.3 
16 1500 500 2000 2.98E-02 0.25 
17 1600 400 2000 2.22E-02 0.2 
18 1700 300 2000 2.01E-02 0.15 
19 1800 200 2000 1.37E-02 0.1 
20 1900 100 2000 8.10E-03 0.05 
21 2000 0 2000 0.00E+00 0 
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8.3 Circular Dichroism 
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Figure 8.5 Circular dichroism spectra of 1) CDEn, 2) CDPn and 3) CDPn 0.002 M in phosphate buffer pH 7.2 
1 
2 
3 
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Figure 8.6 Circular dichroic spectra of 1) L,D- tyrosine (0.001 M) and 2) L,D-DOPA (0.002 M) in phosphate 
buffer pH 7.2  
 
